{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\",\n    \"alternateName\": \"Schwannomatosis Leukocyte Methylation Signatures\",\n    \"creator\": [\n      \"Dr. Gelareh Zadeh\"\n    ],\n    \"contributor\": [\n      \"University Health Network of Toronto\",\n      \"Sheila Mansouri\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"DNA methylation\",\n      \"leukocytes\",\n      \"Schwannomatosis\",\n      \"sporadic schwannoma\",\n      \"immune cells\",\n      \"methylation array\",\n      \"biomarkers\",\n      \"peripheral blood\",\n      \"cell deconvolution\",\n      \"neutrophil to lymphocyte ratio\",\n      \"NLR\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"studyId\": \"syn24875850\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"DNA methylation profiling of peripheral blood leukocytes from 54 individuals (including schwannomatosis and sporadic schwannoma patients). Data generated using methylation arrays was used to evaluate immune cell proportions via cell deconvolution analysis. Results suggest schwannomatosis patients may have a higher neutrophil to lymphocyte ratio (NLR).\",\n    \"individualCount\": 54,\n    \"specimenCount\": 54,\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"DNA methylation\",\n      \"Leukocytes--analysis\",\n      \"Schwannomatosis\",\n      \"Schwannomas\",\n      \"Biomarkers\",\n      \"Immunology\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 770,
            "endIndex": 946,
            "uri": "https://www.synapse.org/Synapse:syn24875850",
            "license": ""
          },
          {
            "startIndex": 4372,
            "endIndex": 4516,
            "uri": "https://www.ctf.org.au/page/112/schwannomatosis",
            "license": ""
          },
          {
            "startIndex": 4403,
            "endIndex": 4543,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5500,
    "candidatesTokenCount": 526,
    "totalTokenCount": 6026,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5500
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn24875850"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"AON Therapy Evaluation NF2\",\n    \"conditionsOfAccess\": \"Data use requires acknowledgement of the data contributors and the NF Data Portal as specified in the project description.\",\n    \"contributor\": [\n      \"Elisabeth Castellanos\",\n      \"James Moon\",\n      \"Catas√∫s, N., et al. (2022) Mol Ther Nucleic Acids\"\n    ],\n    \"creator\": [\n      \"Elisabeth Castellanos\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"geneExpression\",\n      \"proteomics\",\n      \"image\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Patient fibroblast data evaluating antisense oligonucleotides (AONs) designed to correct NF2 splicing or truncating mutations in vitro. Includes results from RT-PCR, Sanger sequencing, Western Blot, immunofluorescence, and proliferation assays after treatment with phosphorodiamidate morpholino oligomers (PMOs).\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 15,\n    \"keywords\": [\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"antisense oligonucleotides\",\n      \"AON\",\n      \"splicing\",\n      \"truncating mutations\",\n      \"personalized therapy\",\n      \"phosphorodiamidate morpholino oligomers\",\n      \"PMOs\",\n      \"exon skipping\",\n      \"merlin\",\n      \"fibroblasts\",\n      \"in vitro\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"polymerase chain reaction\",\n      \"Sanger sequencing\",\n      \"western blot\",\n      \"immunofluorescence\",\n      \"cell proliferation\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn21355225\",\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Antisense Oligonucleotides\",\n      \"Gene Expression Regulation\",\n      \"Therapeutics\",\n      \"Fibroblasts\"\n    ],\n    \"title\": \"Patient Data\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6376,
    "candidatesTokenCount": 580,
    "totalTokenCount": 6956,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6376
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn21355225"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Immunohistochemistry\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Immunohistochemistry data from cutaneous neurofibromas in NF1 patients from the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Immunohistochemistry\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"NFOSI to process 2023-07-21\",\n    \"creator\": [\n      \"Thomas Yu\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NFOSI\",\n      \"Processing\",\n      \"FASTQ\",\n      \"Sequencing\",\n      \"Raw Data\",\n      \"CTF\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Raw sequencing data files (FASTQ) intended for processing by NFOSI, related to the CTF Biobank cutaneous neurofibroma pilot project.\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Sequencing Data\",\n      \"Raw Data\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Proteomics\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Proteomics\",\n      \"MudPIT\",\n      \"Mass Spectrometry\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Proteomics data generated using MudPIT for cutaneous neurofibroma samples from 11 NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"MudPIT\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 40,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Proteomics\",\n      \"Mass Spectrometry\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"RNA-Seq\",\n    \"creator\": [\n      \"Thomas Yu\",\n      \"Sara Gosline\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Processed RNA-Seq data (alignments, counts) from cutaneous neurofibroma samples from NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 44,\n    \"specimenCount\": 33,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Raw cNF RNAseq Files\",\n    \"creator\": [\n      \"CTF\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Raw Data\",\n      \"FASTQ\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Raw RNA-Seq data (FASTQ) from cutaneous neurofibroma samples from 11 NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 33,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Raw Data\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Raw cNF RNAseq Files (unmerged)\",\n    \"creator\": [\n      \"CTF\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Raw Data\",\n      \"FASTQ\",\n      \"Unmerged\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Unmerged raw RNA-Seq data (FASTQ per lane/run) from cutaneous neurofibroma samples from 11 NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 33,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Raw Data\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"SNP\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"SNP\",\n      \"SNP Array\",\n      \"Genomic Variants\",\n      \"Genotyping\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"SNP array data for genotyping cutaneous neurofibroma and matched samples from 11 NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 48,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Genomics\",\n      \"Genotyping\",\n      \"Single Nucleotide Polymorphism\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Sample Information\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Sample Information\",\n      \"Clinical Data\",\n      \"Metadata\",\n      \"Manifest\",\n      \"Protocol\",\n      \"CRF\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"clinical\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Clinical data, sample metadata, manifests, case report forms (CRF), and protocols related to WGS, RNA-Seq, Proteomics, and SNP array data from the CTF Biobank cNF pilot project.\",\n    \"measurementTechnique\": [\n      \"questionnaire\",\n      \"clinical data\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Metadata\",\n      \"Clinical Data\",\n      \"Protocols\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"WGS\",\n    \"creator\": [\n      \"Thomas Yu\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"WGS\",\n      \"Whole Genome Sequencing\",\n      \"Genomic Variants\",\n      \"Somatic Variants\",\n      \"VCF\",\n      \"MAF\",\n      \"BAM\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Whole Genome Sequencing (WGS) data, including variant calls (VCF, MAF) and alignments (BAM), for cutaneous neurofibroma and matched samples from NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 15,\n    \"specimenCount\": 62,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Genomics\",\n      \"Whole Genome Sequencing\",\n      \"Genomic Variation\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"cNF RNA-seq quantification files (salmon)\",\n    \"creator\": [\n      \"CTF\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Quantification\",\n      \"Salmon\",\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Gene and transcript quantification files (.sf) generated using Salmon from RNA-Seq data of cutaneous neurofibromas from NF1 patients, part of the CTF Biobank pilot project.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"CTF\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Quantification\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6995,
    "candidatesTokenCount": 3669,
    "totalTokenCount": 10664,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6995
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4984604"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Copy Number Variation from the Columbia University NF1 Glioma Project\",\n    \"creator\": [\n      \"Antonio Iavarone\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"copy number variation\",\n      \"CNV\",\n      \"glioma\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"whole exome sequencing\",\n      \"Columbia University\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 56,\n    \"specimenCount\": 59,\n    \"contributor\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"description\": \"Copy number variation data derived from whole exome sequencing of tumor and/or normal samples from individuals with NF1-associated glioma. Part of the Columbia University NF1 Glioma Project.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ]\n  },\n  {\n    \"title\": \"CopyNumberVariation - Columbia University NF1 Glioma Project\",\n    \"creator\": [\n      \"Antonio Iavarone\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"copy number variation\",\n      \"CNV\",\n      \"glioma\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"whole exome sequencing\",\n      \"Columbia University\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 56,\n    \"specimenCount\": 59,\n    \"contributor\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"description\": \"Copy number variation data derived from whole exome sequencing of tumor and/or normal samples from individuals with NF1-associated glioma. Part of the Columbia University NF1 Glioma Project.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ]\n  },\n  {\n    \"title\": \"GeneExpression - Columbia University NF1 Glioma Project\",\n    \"creator\": [\n      \"Antonio Iavarone\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"gene expression\",\n      \"RNA-seq\",\n      \"transcriptomics\",\n      \"glioma\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Columbia University\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 29,\n    \"specimenCount\": 32,\n    \"contributor\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"description\": \"Gene expression counts derived from RNA sequencing of tumor and/or normal samples from individuals with NF1-associated glioma. Part of the Columbia University NF1 Glioma Project.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ]\n  },\n  {\n    \"title\": \"Methylation - Columbia University NF1 Glioma Project\",\n    \"creator\": [\n      \"Antonio Iavarone\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"methylation\",\n      \"epigenetics\",\n      \"methylation array\",\n      \"glioma\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Columbia University\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 31,\n    \"specimenCount\": 31,\n    \"contributor\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"description\": \"DNA methylation data generated using methylation arrays on samples from individuals with NF1-associated glioma. Part of the Columbia University NF1 Glioma Project.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ]\n  },\n  {\n    \"title\": \"NucleotideVariation - Columbia University NF1 Glioma Project\",\n    \"creator\": [\n      \"Antonio Iavarone\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"nucleotide variation\",\n      \"SNV\",\n      \"indel\",\n      \"somatic variants\",\n      \"genomic variants\",\n      \"glioma\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"whole exome sequencing\",\n      \"Columbia University\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 56,\n    \"specimenCount\": 102,\n    \"contributor\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"description\": \"Nucleotide variation data (SNVs, indels) identified through whole exome sequencing of tumor and/or normal samples from individuals with NF1-associated glioma. Part of the Columbia University NF1 Glioma Project.\",\n    \"manifestation\": [\n      \"High-Grade Glioma\",\n      \"Low-Grade Glioma\"\n    ]\n  },\n  {\n    \"title\": \"WholeGenomeVariants - Columbia University NF1 Glioma Project\",\n    \"creator\": [\n      \"Antonio Iavarone\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"genomic variants\",\n      \"SNV\",\n      \"indel\",\n      \"VCF\",\n      \"glioma\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Columbia University\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 22,\n    \"contributor\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"description\": \"Genomic variants identified through whole genome sequencing (WGS) of tumor and/or normal samples from individuals with NF1-associated glioma. Part of the Columbia University NF1 Glioma Project.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5875,
    "candidatesTokenCount": 2023,
    "totalTokenCount": 7898,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5875
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn6633069"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"studyId\": \"syn26347297\",\n    \"title\": \"Flow Cytometry Data for MPNST Immune Microenvironment Study\",\n    \"description\": \"Aggregated flow cytometry data characterizing the tumor immune microenvironment in human malignant peripheral nerve sheath tumors (MPNST) and its response to RAS pathway inhibitors.\",\n    \"creator\": [\n      \"Lindy Zhang\"\n    ],\n    \"contributor\": [\n      \"Christine Pratilas\",\n      \"Nicolas Llosa\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Flow Cytometry\",\n      \"MPNST\",\n      \"Neurofibromatosis Type 1\",\n      \"Immune Microenvironment\",\n      \"Immunophenotyping\",\n      \"Drug Response\",\n      \"SHP2 inhibitor\",\n      \"MEK inhibitor\",\n      \"CDK inhibitor\"\n    ],\n    \"dataType\": [\n      \"immunoassay\",\n      \"AggregatedData\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"flow cytometry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Flow cytometry\",\n      \"Immune system\",\n      \"Drug Therapy\",\n      \"Cellular immunity\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"studyId\": \"syn26347297\",\n    \"title\": \"Immunohistochemistry Data for MPNST Immune Microenvironment Study\",\n    \"description\": \"Aggregated immunohistochemistry data analyzing protein expression and the tumor immune microenvironment in human malignant peripheral nerve sheath tumors (MPNST) following treatment with RAS pathway inhibitors.\",\n    \"creator\": [\n      \"Lindy Zhang\"\n    ],\n    \"contributor\": [\n      \"Christine Pratilas\",\n      \"Nicolas Llosa\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"MPNST\",\n      \"Neurofibromatosis Type 1\",\n      \"Immune Microenvironment\",\n      \"Biomarkers\",\n      \"Drug Response\",\n      \"SHP2 inhibitor\",\n      \"MEK inhibitor\",\n      \"CDK inhibitor\"\n    ],\n    \"dataType\": [\n      \"proteomics\",\n      \"AggregatedData\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Immunohistochemistry\",\n      \"Immune system\",\n      \"Drug Therapy\",\n      \"Biomarkers\",\n      \"Protein expression\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 177,
            "endIndex": 316,
            "uri": "https://www.hopkinsmedicine.org/kimmel_cancer_center/education_training/fellowships/pediatric_hematology_oncology/research_in_fellowship.html",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 4991,
    "candidatesTokenCount": 871,
    "totalTokenCount": 5862,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 4991
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn26347297"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Exp008 Analyzed High Throughput Screening Data for MPNST Cell Lines\",\n    \"creator\": [\n      \"Jeffrey Field\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"High Throughput Screening\",\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Drug Sensitivity\",\n      \"Cancer Cell Lines\",\n      \"Drug Screen\",\n      \"Cell Viability\",\n      \"Immunofluorescence\",\n      \"Analyzed Data\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"MPNST HTS Analyzed Data (Exp008)\",\n    \"description\": \"Analyzed data from high throughput screening experiment Exp008, evaluating drug sensitivity in MPNST cell lines using cell viability assays and immunofluorescence imaging. Part of a research/education project. Includes normalized data and analysis templates.\",\n    \"contributor\": [\n      \"Jeffrey Field\",\n      \"yang yang\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\",\n      \"immunofluorescence\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Neurofibromatosis Type 1\",\n      \"Drug screening\",\n      \"Cell lines\"\n    ]\n  },\n  {\n    \"title\": \"Raw Data and Logs from High Throughput Drug Screens on NF Cell Lines\",\n    \"creator\": [\n      \"Jeffrey Field\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"High Throughput Screening\",\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Schwannoma\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Neurofibromatosis type 2\",\n      \"NF2\",\n      \"Drug Sensitivity\",\n      \"Cancer Cell Lines\",\n      \"Drug Screen\",\n      \"Cell Viability\",\n      \"Raw Data\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF HTS Raw Data and Logs\",\n    \"description\": \"Raw instrument output data and associated logs from high throughput drug screens assessing cell viability on Neurofibromatosis type 1 (NF1) and type 2 (NF2) associated cell lines, including MPNST and Schwannoma. Part of a research/education project.\",\n    \"contributor\": [\n      \"Jeffrey Field\",\n      \"yang yang\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Schwannoma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Rattus norvegicus\"\n    ],\n    \"specimenCount\": 27,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 1\",\n      \"Neurofibromatosis Type 2\",\n      \"Drug screening\",\n      \"Cell lines\",\n      \"Rats\"\n    ]\n  },\n  {\n    \"title\": \"Exome Sequencing Data for Neurofibromatosis Cell Lines\",\n    \"creator\": [\n      \"Jeffrey Field\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Whole Exome Sequencing\",\n      \"WES\",\n      \"Genomics\",\n      \"Genomic Variants\",\n      \"VCF\",\n      \"MAF\",\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Schwannoma\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Neurofibromatosis type 2\",\n      \"NF2\",\n      \"Cancer Cell Lines\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF Cell Line Exome Sequencing\",\n    \"description\": \"Whole exome sequencing (WES) data, including genomic variants (VCF, MAF), for cell lines related to Neurofibromatosis type 1 (NF1) and type 2 (NF2), including Malignant Peripheral Nerve Sheath Tumor (MPNST) and Schwannoma samples.\",\n    \"contributor\": [\n      \"Jeffrey Field\",\n      \"Robert Allaway\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Schwannoma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 13,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Exome sequencing\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 1\",\n      \"Neurofibromatosis Type 2\",\n      \"Cell lines\",\n      \"Genomics\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5988,
    "candidatesTokenCount": 1486,
    "totalTokenCount": 7474,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5988
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11817821"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Combination Index Validation Studies: In Vitro Drug Screen Data\",\n    \"creator\": [\n      \"D. Wade Clapp\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug combination\",\n      \"validation study\",\n      \"in vitro\",\n      \"cell viability assay\",\n      \"drug screen\",\n      \"Schwann cell\",\n      \"MTC\",\n      \"ipNF 95.6\",\n      \"ipNF 05.5\",\n      \"MPC\",\n      \"Plexiform Neurofibroma\",\n      \"Neurofibromatosis type 1\",\n      \"Rapamycin\",\n      \"Ganetespib\",\n      \"Selumetinib\",\n      \"Panobinostat\",\n      \"cell culture\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn4939876\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"alternateName\": \"Combination Index Validation Studies - Spreadsheets\",\n    \"contributor\": [\n      \"Heather Daniel\",\n      \"Xindi Guo\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"In vitro validation data for two drug combinations (Rapamycin & Ganetespib, Selumetinib & Panobinostat) tested on murine Schwann cells, MTC, ipNF 95.6, ipNF 05.5, and MPC cell lines. Includes cell viability assay results comparing Caspase-Glo, CellTiter-Glo, and MTT reagents. Focuses on Plexiform Neurofibroma associated with Neurofibromatosis type 1.\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Plexiform neurofibroma\",\n      \"Drug screening\",\n      \"Cell lines\",\n      \"Antineoplastic agents\",\n      \"Cell viability\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5299,
    "candidatesTokenCount": 550,
    "totalTokenCount": 5849,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5299
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939876"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Cell Viability Celigo Assays\",\n    \"creator\": [\n      \"Laurel Black\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"cell viability\",\n      \"Celigo assay\",\n      \"drug screen\",\n      \"drug combination screen\",\n      \"image\",\n      \"gene expression\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"cell viability assay\",\n      \"image\",\n      \"geneExpression\",\n      \"drugScreen\",\n      \"drugCombinationScreen\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"conditionsOfAccess\": \"Synapse registration required\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Cell viability assay data, including images, gene expression, single drug, and combination drug screens for Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Generated using Celigo imaging cytometer.\"\n  },\n  {\n    \"title\": \"Imaging\",\n    \"creator\": [\n      \"Laurel Black\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"immunocytochemistry\",\n      \"imaging\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"conditionsOfAccess\": \"Synapse registration required\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"immunocytochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Immunocytochemistry imaging data for Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines, likely related to ErbB3 expression.\"\n  },\n  {\n    \"title\": \"Kinomics\",\n    \"creator\": [\n      \"Laurel Black\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"kinomics\",\n      \"immunoassay\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"conditionsOfAccess\": \"Synapse registration required\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"immunoassay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Kinomics data generated via immunoassay for Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines, likely exploring kinase phosphorylation states related to ErbB3 and calcium signaling pathways.\"\n  },\n  {\n    \"title\": \"Microarray\",\n    \"creator\": [\n      \"Laurel Black\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"microarray\",\n      \"gene expression\",\n      \"Schwann cells\",\n      \"Rattus norvegicus\",\n      \"NRG1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Laurel Black\",\n      \"James Moon\"\n    ],\n    \"conditionsOfAccess\": \"Synapse registration required\",\n    \"individualCount\": 1,\n    \"specimenCount\": 1,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"array\"\n    ],\n    \"species\": [\n      \"Rattus norvegicus\"\n    ],\n    \"description\": \"Microarray gene expression data from Rattus norvegicus (rat) adult Schwann cells, exploring genes regulated by NRG1 beta stimulation, relevant to MPNST pathogenesis.\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6067,
    "candidatesTokenCount": 1315,
    "totalTokenCount": 7382,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6067
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn22267330"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Analysis Data for cNF Optical Imaging Study\",\n    \"creator\": [\n      \"Wangcun Jia\",\n      \"Junsoo Lee\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"cutaneous neurofibroma\",\n      \"cNF\",\n      \"optical imaging\",\n      \"SFDI\",\n      \"OCT\",\n      \"image analysis\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"University of California, Irvine\",\n      \"Thomas E. Milner\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"spatial frequency domain imaging\",\n      \"optical coherence tomography\"\n    ],\n    \"description\": \"Processed images and analysis results derived from Spatial Frequency Domain Imaging (SFDI) and Optical Coherence Tomography (OCT) scans of cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 patients.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Skin--Tumors\",\n      \"Diagnostic Imaging\"\n    ]\n  },\n  {\n    \"title\": \"Histology Images for cNF Optical Imaging Study Validation\",\n    \"creator\": [\n      \"Wangcun Jia\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"cutaneous neurofibroma\",\n      \"cNF\",\n      \"histology\",\n      \"validation\",\n      \"brightfield microscopy\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"University of California, Irvine\",\n      \"Thomas E. Milner\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"brightfield microscopy\"\n    ],\n    \"description\": \"Brightfield microscopy images of histological sections from cutaneous neurofibromas (cNF) and uninvolved skin, used for validating optical imaging findings in Neurofibromatosis type 1 patients.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Skin--Tumors\",\n      \"Histology\",\n      \"Microscopy\"\n    ]\n  },\n  {\n    \"title\": \"Raw OCT Image Data for cNF Study\",\n    \"creator\": [\n      \"Junsoo Lee\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"cutaneous neurofibroma\",\n      \"cNF\",\n      \"optical coherence tomography\",\n      \"OCT\",\n      \"raw data\",\n      \"imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"University of California, Irvine\",\n      \"Thomas E. Milner\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"optical coherence tomography\"\n    ],\n    \"description\": \"Raw image data generated using Optical Coherence Tomography (OCT) for the study of cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 patients. Includes attenuation and cross-sectional depth visualization files.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Skin--Tumors\",\n      \"Diagnostic Imaging\",\n      \"Tomography, Optical Coherence\"\n    ]\n  },\n  {\n    \"title\": \"Clinical Photographs for cNF Study Participants\",\n    \"creator\": [\n      \"Wangcun Jia\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"cutaneous neurofibroma\",\n      \"cNF\",\n      \"clinical photos\",\n      \"photography\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"University of California, Irvine\",\n      \"Thomas E. Milner\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"photograph\"\n    ],\n    \"description\": \"Clinical photographs documenting the appearance of cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 study participants.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Skin--Tumors\",\n      \"Medical photography\"\n    ]\n  },\n  {\n    \"title\": \"Raw SFDI Image Data for cNF Study\",\n    \"creator\": [\n      \"Wangcun Jia\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"cutaneous neurofibroma\",\n      \"cNF\",\n      \"spatial frequency domain imaging\",\n      \"SFDI\",\n      \"raw data\",\n      \"imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"University of California, Irvine\",\n      \"Thomas E. Milner\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"spatial frequency domain imaging\"\n    ],\n    \"description\": \"Raw image and metadata files generated using Spatial Frequency Domain Imaging (SFDI) for the study of cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 patients. Includes calibration and raw data files.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Skin--Tumors\",\n      \"Diagnostic Imaging\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5895,
    "candidatesTokenCount": 1984,
    "totalTokenCount": 7879,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5895
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn31619419"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Gene expression profiling of Schwann cells and macrophages in mouse nerves and neurofibromas\",\n    \"creator\": [\n      \"Jianqiang Wu\",\n      \"Kakajan Komurov\"\n    ],\n    \"contributor\": [\n      \"Kwangmn Choi\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"gene expression\",\n      \"microarray\",\n      \"Schwann cell\",\n      \"macrophage\",\n      \"neurofibroma\",\n      \"plexiform neurofibroma\",\n      \"Mus musculus\",\n      \"NF1\",\n      \"inflammation\",\n      \"interactome\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"RawIntensities\"\n    ],\n    \"studyId\": \"syn4939890\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Gene expression profiles from Affymetrix Mouse Gene 2.0 ST arrays comparing Schwann cells and macrophages isolated from mouse nerves and plexiform neurofibromas. This dataset aims to characterize cellular gene expression changes and intercellular signaling during neurofibroma progression.\",\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA array\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Gene expression\",\n      \"Neurofibromatosis 1\",\n      \"Plexiform neurofibroma\",\n      \"Macrophages\",\n      \"Schwann cells\",\n      \"Mice\",\n      \"Inflammation\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5786,
    "candidatesTokenCount": 441,
    "totalTokenCount": 6227,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5786
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939890"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Drug Screen Data from 3D Plexiform Neurofibroma Model System\",\n    \"creator\": [\n      \"Ray Mattingly\"\n    ],\n    \"contributor\": [\n      \"Anh Nguyet Vu\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug screen\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"3D culture\",\n      \"preclinical model\",\n      \"cell culture\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"measurementTechnique\": [\n      \"drugScreen\",\n      \"cell proliferation\",\n      \"3D microtissue viability\"\n    ],\n    \"studyId\": \"syn7217928\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Drug screen results derived from experiments using 3D co-culture models of NF1 plexiform neurofibromas (PNs) developed for preclinical drug screening.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Drug Screens with 3D Plexiform Neurofibroma Model System\",\n    \"creator\": [\n      \"Ray Mattingly\"\n    ],\n    \"contributor\": [\n      \"Anh Nguyet Vu\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug screen\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"3D culture\",\n      \"preclinical model\",\n      \"cell culture\",\n      \"model system\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"measurementTechnique\": [\n      \"drugScreen\",\n      \"cell proliferation\",\n      \"3D microtissue viability\"\n    ],\n    \"studyId\": \"syn7217928\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Results from drug screens conducted using a developed 3D co-culture model system designed to represent NF1 plexiform neurofibromas for preclinical testing.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6036,
    "candidatesTokenCount": 701,
    "totalTokenCount": 6737,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6036
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn7217928"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Mayo Clinic cohort REDCap database of de-identified phenotype and genotype information\",\n    \"creator\": [\n      \"Mayowa Osundiji\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"Mayo Clinic NF1 EHR Data\",\n    \"contributor\": [\n      \"Mayowa Osundiji\",\n      \"Marlene Girardo\",\n      \"Mayo Clinic Arizona\"\n    ],\n    \"dataType\": [\n      \"clinical\",\n      \"AggregatedData\"\n    ],\n    \"description\": \"De-identified clinical phenotype and genotype information extracted from Mayo Clinic Rochester Electronic Health Records (EHRs) for Neurofibromatosis type 1 patients, collected via REDCap. Part of an effort to supplement the CTF-NF Registry.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 1,\n    \"keywords\": [\n      \"Neurofibromatosis\",\n      \"NF1\",\n      \"Electronic Health Records\",\n      \"EHR\",\n      \"Clinical Data\",\n      \"Genotype\",\n      \"Phenotype\",\n      \"Registry\",\n      \"Mayo Clinic\",\n      \"MPNST\",\n      \"REDCap\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"genotyping\",\n      \"clinical data\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn61696875\",\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Electronic health records\",\n      \"Medical genetics\",\n      \"Phenotype\",\n      \"Genotype\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 418,
            "endIndex": 558,
            "uri": "https://staging.synapse.org/Profile:3423450",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5245,
    "candidatesTokenCount": 441,
    "totalTokenCount": 5686,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5245
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn61696875"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"2017 Release - Jumping Library Seq\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Jumping Library\",\n      \"Structural Rearrangement\",\n      \"Chromosomal Abnormalities\",\n      \"Genomic Variants\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2017 Release\"\n    ],\n    \"dataType\": [\n      \"StructuralVariants\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 12,\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"jumping library\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"description\": \"Processed genomic variant data detecting chromosomal abnormalities (e.g., pathogenic breakpoints) from 11 human and mouse cell line models of meningioma and schwannoma with NF2 wildtype or NF2 deficient status. Data generated using jumping library sequencing as part of the 2017 Synodos for NF2 data release.\"\n  },\n  {\n    \"title\": \"2017 Release - Proteomics_Kinome\",\n    \"creator\": [\n      \"Abhishek Pratap\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Proteomics\",\n      \"Kinomics\",\n      \"MIB/MS\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2017 Release\",\n      \"Drug Treatment\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 9,\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"MIB/MS\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\",\n      \"Meningioma\"\n    ],\n    \"description\": \"Processed kinomics data from 11 human and mouse cell line models of NF2-related meningioma and schwannoma, including responses to drug treatments. Generated using Multiplexed Inhibitor Beads and Mass Spectrometry (MIB/MS) as part of the 2017 Synodos for NF2 data release.\"\n  },\n  {\n    \"title\": \"2019 Release - Animal Studies\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Animal Model\",\n      \"In Vivo\",\n      \"Bioluminescence\",\n      \"Tumor Volume\",\n      \"Drug Treatment\",\n      \"Meningioma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2019 Release\"\n    ],\n    \"dataType\": [\n      \"Volume\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"specimenCount\": 2,\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"in vivo bioluminescence\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\"\n    ],\n    \"description\": \"Animal study data measuring tumor volume changes, potentially using in vivo bioluminescence, in response to treatments like GSK458, Panobinostat, CUDC907, MK2206, and Brigatinib in meningioma models related to NF2. Part of the 2019 Synodos for NF2 data release.\"\n  },\n  {\n    \"title\": \"2019 Release - High-Throughput Drug Screens\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"High-Throughput Screening\",\n      \"HTS\",\n      \"Drug Screen\",\n      \"Cell Viability\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2019 Release\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 7,\n    \"specimenCount\": 15,\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\",\n      \"Meningioma\"\n    ],\n    \"description\": \"High-throughput drug screening data assessing cell viability in 7 human and mouse cell line models of NF2-related meningioma and schwannoma. Part of the 2019 Synodos for NF2 data release.\"\n  },\n  {\n    \"title\": \"2019 Release - Proteomics_Kinome\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Proteomics\",\n      \"Kinomics\",\n      \"Immunoassay\",\n      \"ELISA\",\n      \"MIB/MS\",\n      \"Drug Treatment\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2019 Release\"\n    ],\n    \"dataType\": [\n      \"kinomics\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 3,\n    \"specimenCount\": 2,\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"MIB/MS\",\n      \"sandwich ELISA\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"description\": \"Proteomics (kinomics) and immunoassay data from human and mouse models of NF2-related meningioma and schwannoma, including responses to drug treatments (e.g., MK2206, Brigatinib). Generated using MIB/MS and sandwich ELISA. Part of the 2019 Synodos for NF2 data release.\"\n  },\n  {\n    \"title\": \"2019 Release - RNASeq\",\n    \"creator\": [\n      \"Serkan Erdin\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2019 Release\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 109,\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"description\": \"RNA sequencing data (including aligned reads and potentially processed expression) from human and mouse cell line models of NF2-related meningioma and schwannoma. Part of the 2019 Synodos for NF2 data release.\"\n  },\n  {\n    \"title\": \"2021 - Raw Blot Images\",\n    \"creator\": [\n      \"Abbi Smith\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Blot Images\",\n      \"Raw Data\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2021 Release\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"description\": \"Raw image files, likely from Western blots, related to the Synodos for NF2 project. Released in 2021.\"\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Quantification\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 2,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"description\": \"Processed gene expression quantification data derived from RNA sequencing of human schwannoma samples related to NF2.\"\n  },\n  {\n    \"title\": \"NF-OSI RNASeq Reprocessing\",\n    \"creator\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Quantification\",\n      \"Reprocessed Data\",\n      \"Meningioma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"NF-OSI\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 75,\n    \"specimenCount\": 84,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\"\n    ],\n    \"series\": \"NF-OSI Processed Data\",\n    \"description\": \"Reprocessed RNA sequencing gene expression quantification data from human meningioma samples related to NF2. Processed by the NF-OSI team.\"\n  },\n  {\n    \"title\": \"Synodos NF2 Drug Screen - 2017 Release\",\n    \"creator\": [\n      \"Abhishek Pratap\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Drug Screen\",\n      \"Cell Viability\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2017 Release\",\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"description\": \"Drug screening data, likely assessing cell viability, from the Synodos for NF2 project 2017 release. Contains both raw and processed data.\"\n  },\n  {\n    \"title\": \"Synodos NF2 Processed RNA-seq - 2017 Release\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Processed Data\",\n      \"Differential Expression\",\n      \"Raw Counts\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2017 Release\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"description\": \"Processed RNA sequencing data from the Synodos for NF2 project 2017 release, including raw counts and differential gene expression analysis for meningioma and schwannoma models (human and mouse).\"\n  },\n  {\n    \"title\": \"Synodos NF2 RNA-seq Raw Data - 2017 Release\",\n    \"creator\": [\n      \"Steven Angus\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Raw Data\",\n      \"FASTQ\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"2017 Release\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 47,\n    \"specimenCount\": 205,\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\",\n      \"Meningioma\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ files) from 47 human and mouse samples (cell lines/tissues) related to NF2 meningioma and schwannoma models. Part of the 2017 Synodos for NF2 data release.\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7933,
    "candidatesTokenCount": 3918,
    "totalTokenCount": 11851,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7933
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn2343195"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"flow cytometry\",\n      \"gene expression\",\n      \"image\",\n      \"cell cycle\",\n      \"karyotyping\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Cell cycle, quantitative PCR, karyotyping, and staining data generated at the 12-month mark for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"flow cytometry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  },\n  {\n    \"title\": \"18 month deliverables\",\n    \"creator\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"western blot\",\n      \"flow cytometry\",\n      \"quantitative PCR\",\n      \"immunohistochemistry\",\n      \"immunofluorescence\",\n      \"image\",\n      \"apoptosis\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Western blot, Annexin V-PI staining, quantitative PCR, immunostaining, and FACS data generated at the 18-month mark for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"western blot\",\n      \"flow cytometry\",\n      \"quantitative PCR\",\n      \"immunohistochemistry\",\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  },\n  {\n    \"title\": \"24 month deliverables\",\n    \"creator\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"western blot\",\n      \"quantitative PCR\",\n      \"immunofluorescence\",\n      \"immunocytochemistry\",\n      \"gene expression\",\n      \"immunoassay\",\n      \"FACS\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"immunoassay\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Western blot, quantitative PCR, FACS analysis, and immunostaining data generated at the 24-month mark for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"western blot\",\n      \"quantitative PCR\",\n      \"immunofluorescence\",\n      \"immunocytochemistry\",\n      \"flow cytometry\"\n    ],\n    \"specimenCount\": 1,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  },\n  {\n    \"title\": \"30 month deliverables\",\n    \"creator\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"immunocytochemistry\",\n      \"atomic force microscopy\",\n      \"immunofluorescence\",\n      \"RNA-seq\",\n      \"quantitative PCR\",\n      \"immunoassay\",\n      \"image\",\n      \"gene expression\",\n      \"FACS\",\n      \"TEM\"\n    ],\n    \"dataType\": [\n      \"immunoassay\",\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"FACS sorting, RNA-seq, MBP staining, and TEM data generated at the 30-month mark for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"immunocytochemistry\",\n      \"atomic force microscopy\",\n      \"immunofluorescence\",\n      \"RNA-seq\",\n      \"quantitative PCR\",\n      \"flow cytometry\",\n      \"3D electron microscopy\"\n    ],\n    \"specimenCount\": 1,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  },\n  {\n    \"title\": \"36 month deliverables\",\n    \"creator\": [\n      \"Gabsang Lee\",\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"cell viability assay\",\n      \"quantitative PCR\",\n      \"atomic force microscopy\",\n      \"RNA-seq\",\n      \"immunofluorescence\",\n      \"cellular physiology\",\n      \"gene expression\",\n      \"image\",\n      \"immunoassay\",\n      \"TEM\"\n    ],\n    \"dataType\": [\n      \"cellularPhysiology\",\n      \"geneExpression\",\n      \"image\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"RNA-seq, cell cycle analysis, cell proliferation assay, quantitative PCR, and TEM imaging data generated at the 36-month mark for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"cell viability assay\",\n      \"quantitative PCR\",\n      \"atomic force microscopy\",\n      \"RNA-seq\",\n      \"immunofluorescence\",\n      \"flow cytometry\",\n      \"3D electron microscopy\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 16,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\",\n      \"NF Service\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"Sanger sequencing\",\n      \"genomic variants\",\n      \"donor vector\",\n      \"transfection\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data related to donor vector construction, transfection, sequencing, and expansion generated at the 6-month mark for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"Sanger sequencing\",\n      \"polymerase chain reaction\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"quantification\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Processed gene expression quantification data derived from RNA-seq experiments related to the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 16,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"NF Service\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ],\n    \"series\": \"NF-OSI Processed Data\"\n  },\n  {\n    \"title\": \"Raw RNA-Seq Data for NF-OSI Processing (2023-03-14)\",\n    \"creator\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cell\",\n      \"hESC\",\n      \"SMASh\",\n      \"gene editing\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"raw data\",\n      \"fastq\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ files) submitted for processing by NF-OSI on 2023-03-14, generated for the study modeling NF1 using human Schwann cells derived from hESCs with tunable NF1 control.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Gabsang Lee\",\n      \"Johns Hopkins University\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Schwann cells\",\n      \"Stem cells\",\n      \"Gene editing\",\n      \"Disease models, Cellular\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6532,
    "candidatesTokenCount": 3342,
    "totalTokenCount": 9874,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6532
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374349"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Synodos LGG Methylation Arrays\",\n    \"creator\": [\n      \"Synodos for NF1 - Low Grade Glioma\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"methylation\",\n      \"array\",\n      \"LGG\",\n      \"low grade glioma\",\n      \"Neurofibromatosis type 1\",\n      \"Pilocytic Astrocytoma\",\n      \"Pilomyxoid Astrocytoma\",\n      \"Diffuse Astrocytoma\",\n      \"Glioblastoma Multiforme\",\n      \"Anaplastic Astrocytoma\",\n      \"Pleomorphic Xanthoastrocytoma\",\n      \"chromatinActivity\",\n      \"idat\",\n      \"epigenomics\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn5698493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 43,\n    \"specimenCount\": 43,\n    \"description\": \"Methylation array data (IDAT files) from tumor specimens of individuals with Neurofibromatosis Type 1-associated Low-Grade Glioma (LGG). Includes various glioma subtypes.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"Glioma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Methylation\",\n      \"Astrocytoma\",\n      \"Epigenomics\"\n    ],\n    \"alternateName\": \"NF1 LGG Methylation Data\"\n  },\n  {\n    \"title\": \"Synodos LGG RNAseq\",\n    \"creator\": [\n      \"Synodos for NF1 - Low Grade Glioma\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"LGG\",\n      \"low grade glioma\",\n      \"Neurofibromatosis type 1\",\n      \"Pilocytic Astrocytoma\",\n      \"Pleomorphic Xanthoastrocytoma\",\n      \"Diffuse Astrocytoma\",\n      \"Pilomyxoid Astrocytoma\",\n      \"fastq\",\n      \"transcriptomics\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn5698493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\",\n      \"3D microtissue viability\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 23,\n    \"specimenCount\": 23,\n    \"description\": \"RNA sequencing data (fastq files) from tumor specimens of individuals with Neurofibromatosis Type 1-associated Low-Grade Glioma (LGG). Includes various glioma subtypes.\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"Glioma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"RNA Sequencing\",\n      \"Astrocytoma\",\n      \"Gene expression\",\n      \"Transcriptome\"\n    ],\n    \"alternateName\": \"NF1 LGG RNA Sequencing Data\"\n  },\n  {\n    \"title\": \"Synodos LGG Whole Genome Sequencing (bam)\",\n    \"creator\": [\n      \"Synodos for NF1 - Low Grade Glioma\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"genomic variants\",\n      \"LGG\",\n      \"low grade glioma\",\n      \"Neurofibromatosis type 1\",\n      \"Pilocytic Astrocytoma\",\n      \"Pilomyxoid Astrocytoma\",\n      \"Diffuse Astrocytoma\",\n      \"Atypical Pilocytic Astrocytoma\",\n      \"bam\",\n      \"genomics\",\n      \"aligned reads\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn5698493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 22,\n    \"specimenCount\": 44,\n    \"description\": \"Whole Genome Sequencing (WGS) alignment data (BAM files) from tumor and matched normal specimens of individuals with Neurofibromatosis Type 1-associated Low-Grade Glioma (LGG).\",\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"Glioma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Whole genome sequencing\",\n      \"Astrocytoma\",\n      \"Genomics\",\n      \"Sequence alignment\"\n    ],\n    \"alternateName\": \"NF1 LGG WGS BAM Data\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5825,
    "candidatesTokenCount": 1374,
    "totalTokenCount": 7199,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5825
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn5698493"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Animal Tumor Growth Studies for NF1-MPNST PDX Lines\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"tumor growth\",\n      \"in vivo\",\n      \"PDX\",\n      \"MPNST\",\n      \"NF1\",\n      \"drug screen\",\n      \"preclinical model\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Ana Calizo\",\n      \"Himanshi Bhatia\",\n      \"Daniel Schefer\"\n    ],\n    \"individualCount\": 9,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"in vivo tumor growth\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"In vivo tumor growth data from drug screening studies using NF1-MPNST patient-derived xenograft (PDX) models in mice.\"\n  },\n  {\n    \"title\": \"Batch 1 RNA-seq Data from Drug Treated NF1-MPNST Cell Lines\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"drug treatment\",\n      \"cell lines\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Batch 1 RNA sequencing data assessing gene expression changes in NF1-MPNST derived cell lines following drug treatment.\"\n  },\n  {\n    \"title\": \"Annotation Files for Cell Growth Data\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"annotation\",\n      \"metadata\",\n      \"cell growth\",\n      \"drug screen\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Annotation files providing metadata for associated cell growth datasets from NF1-MPNST studies.\"\n  },\n  {\n    \"title\": \"Drug Combination Screening Data using Incucyte System\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug combination\",\n      \"drug screen\",\n      \"Incucyte\",\n      \"cell viability\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"High-throughput cell viability data from drug combination screens performed using the Incucyte live-cell imaging system on NF1-MPNST models.\"\n  },\n  {\n    \"title\": \"Batch 2 RNA-seq Data from NF1-MPNST Patient and PDX Samples\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"fastq\",\n      \"PDX\",\n      \"patient samples\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Kuangying Yang\",\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 16,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Batch 2 RNA sequencing data (FASTQ files) generated from Neurofibromatosis type 1 patient tumor samples and corresponding patient-derived xenografts (PDX).\"\n  },\n  {\n    \"title\": \"Incucyte Drug Response Data for NF1-MPNST PDX-derived Cells\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Incucyte\",\n      \"drug screen\",\n      \"drug response\",\n      \"cell viability\",\n      \"MPNST\",\n      \"NF1\",\n      \"PDX\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Ana Calizo\"\n    ],\n    \"individualCount\": 4,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Drug response data generated using the Incucyte system to assess cell viability in NF1-MPNST PDX-derived cell cultures treated with various compounds.\"\n  },\n  {\n    \"title\": \"Whole Exome Sequencing Somatic Variant Calls (MAF) - JH Samples\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"WES\",\n      \"somatic variants\",\n      \"genomic variants\",\n      \"MAF\",\n      \"MPNST\",\n      \"NF1\",\n      \"Johns Hopkins\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 6,\n    \"specimenCount\": 6,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Somatic variant calls in MAF format derived from whole exome sequencing (WES) of Johns Hopkins (JH) tumor samples from the NF1-MPNST study.\"\n  },\n  {\n    \"title\": \"Batch 2 Whole Exome Sequencing Data (FASTQ) - MGI\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"WES\",\n      \"genomic variants\",\n      \"fastq\",\n      \"MPNST\",\n      \"Atypical Neurofibroma\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 21,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"description\": \"Batch 2 raw whole exome sequencing data (FASTQ files) from McDonnell Genome Institute (MGI) for NF1-MPNST and Atypical Neurofibroma samples.\"\n  },\n  {\n    \"title\": \"Batch 2 Aligned Whole Exome Sequencing Data (BAM) - MGI\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"WES\",\n      \"aligned reads\",\n      \"BAM\",\n      \"MPNST\",\n      \"Atypical Neurofibroma\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"description\": \"Batch 2 aligned whole exome sequencing data (BAM/BAI files) from McDonnell Genome Institute (MGI) for NF1-MPNST and Atypical Neurofibroma samples.\"\n  },\n  {\n    \"title\": \"Batch 2 Whole Genome Sequencing Data (FASTQ) - MGI\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"genomic variants\",\n      \"fastq\",\n      \"MPNST\",\n      \"Atypical Neurofibroma\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 22,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"description\": \"Batch 2 raw whole genome sequencing data (FASTQ files) from McDonnell Genome Institute (MGI) for NF1-MPNST and Atypical Neurofibroma samples.\"\n  },\n  {\n    \"title\": \"Batch 2 Aligned Whole Genome Sequencing Data (BAM) - MGI\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"aligned reads\",\n      \"BAM\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Batch 2 aligned whole genome sequencing data (BAM/BAI files) from McDonnell Genome Institute (MGI) for NF1-MPNST study samples.\"\n  },\n  {\n    \"title\": \"Batch 1 Aligned Whole Exome Sequencing Data (BAM) - MGI 2020\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"WES\",\n      \"aligned reads\",\n      \"BAM\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 27,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Batch 1 aligned whole exome sequencing data (BAM/BAI files) from McDonnell Genome Institute (MGI) generated in 2020 for the NF1-MPNST study.\"\n  },\n  {\n    \"title\": \"NF-OSI Processed Genomics Data (01/24/2023)\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF-OSI\",\n      \"processed data\",\n      \"genomics\",\n      \"BAM\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\",\n      \"NF-OSI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Genomic data processed by the NF-OSI initiative on 01/24/2023, likely containing aligned reads (BAM) related to the NF1-MPNST project.\"\n  },\n  {\n    \"title\": \"NF-OSI Processed Genomics Data (12/19/2022)\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF-OSI\",\n      \"processed data\",\n      \"genomics\",\n      \"BAM\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\",\n      \"NF-OSI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Genomic data processed by the NF-OSI initiative on 12/19/2022, likely containing aligned reads (BAM) related to the NF1-MPNST project.\"\n  },\n  {\n    \"title\": \"Proteomics and Phosphoproteomics Data for NF1-MPNST Study\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"phosphoproteomics\",\n      \"mass spectrometry\",\n      \"MPNST\",\n      \"NF1\",\n      \"FISH\",\n      \"metadata\"\n    ],\n    \"dataType\": [\n      \"proteomics\",\n      \"image\",\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\",\n      \"Camilo Posso\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"mass spectrometry\",\n      \"Fluorescence In Situ Hybridization\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Global proteomics, phosphoproteomics (likely via mass spectrometry), and Fluorescence In Situ Hybridization (FISH) metadata for samples from the NF1-MPNST preclinical platform project.\"\n  },\n  {\n    \"title\": \"Sample Annotation for NF1-MPNST PDX Batches\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"annotation\",\n      \"metadata\",\n      \"sample information\",\n      \"PDX\",\n      \"MPNST\",\n      \"NF1\"\n    ],\n    \"dataType\": [\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Annotation file containing sample information for Washington University (WU) PDX batches used in the NF1-MPNST study.\"\n  },\n  {\n    \"title\": \"Somatic Variant Calls (MAF) from WES - 2020 Batch\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"WES\",\n      \"somatic variants\",\n      \"genomic variants\",\n      \"MAF\",\n      \"MPNST\",\n      \"NF1\",\n      \"PDX\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Somatic variant calls in MAF format derived from whole exome sequencing (WES) of NF1-MPNST PDX samples from the 2020 batch.\"\n  },\n  {\n    \"title\": \"Updated Somatic Variant Calls (MAF) from WES\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"WES\",\n      \"somatic variants\",\n      \"genomic variants\",\n      \"MAF\",\n      \"MPNST\",\n      \"Atypical Neurofibroma\",\n      \"NF1\",\n      \"PDX\",\n      \"tumor\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"individualCount\": 7,\n    \"specimenCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"description\": \"Updated somatic variant calls (MAF format) from whole exome sequencing (WES) of NF1-MPNST and Atypical Neurofibroma tumor and PDX samples.\"\n  },\n  {\n    \"title\": \"Copy Number Variation Analysis (CNVkit) from WGS - MGI 2020\",\n    \"creator\": [\n      \"Angela Hirbe\",\n      \"David Largaespada\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"copy number variation\",\n      \"CNV\",\n      \"CNVkit\",\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"MPNST\",\n      \"NF1\",\n      \"PDX\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Copy number variation analysis results generated using CNVkit from whole genome sequencing (WGS) data of NF1-MPNST PDX samples (MGI 2020, Batch 2).\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 9962,
    "candidatesTokenCount": 6534,
    "totalTokenCount": 16496,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 9962
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn21984813"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"CTF-UCF-Cenix Complete Compound Drug Screen\",\n    \"alternateName\": \"NF2 High Content Drug Screen (UCF/Cenix)\",\n    \"creator\": [\n      \"Abhishek Pratap\"\n    ],\n    \"contributor\": [\n      \"Children's Tumor Foundation\",\n      \"Dr. Cristina Fernandez-Valle\",\n      \"Cenix Bioscience\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF2\",\n      \"Schwann cells\",\n      \"drug screen\",\n      \"high content screen\",\n      \"phenotypic screen\",\n      \"merlin\",\n      \"EdU\",\n      \"mouse model\",\n      \"Cenix\",\n      \"UCF\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"cellularPhysiology\"\n    ],\n    \"studyId\": \"syn5562324\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Results from a high-content phenotypic drug screen assessing 95 compounds on NF2-/- (MS01) and NF2 wild-type (MS11) mouse Schwann cells. Nuclear phenotypes including EdU incorporation, cell count, size, and morphology were measured after 48h treatment using automated microscopy.\",\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"high content screen\",\n      \"cell proliferation\",\n      \"drugScreen\",\n      \"brightfield microscopy\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Schwann cells\",\n      \"Drug screening\",\n      \"Phenotype\",\n      \"High-throughput screening assays (Drug development)\",\n      \"Mice as laboratory animals\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5066,
    "candidatesTokenCount": 473,
    "totalTokenCount": 5539,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5066
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn5562324"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line Methylation EPIC Array\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"Methylation array data for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines used to assess genomic and epigenomic characteristics, including potential misdiagnoses. Part of a deep characterization study published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"methylation array\",\n      \"epigenomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"IDAT\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Epigenomics\",\n      \"DNA methylation\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"MPNST Cell Line Methylation Arrays\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line SNP Microarray\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"SNP array data for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines used to assess genomic characteristics, including potential misdiagnoses. Part of a deep characterization study published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"SNP array\",\n      \"genomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"copy number variation\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Single nucleotide polymorphisms\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"MPNST Cell Line SNP Arrays\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line WES FASTQ Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"Whole exome sequencing (WES) raw data (FASTQ) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Used for deep genomic characterization. Part of a study published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"whole exome sequencing\",\n      \"WES\",\n      \"genomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"FASTQ\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Exome sequencing\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"MPNST Cell Line Whole Exome Sequencing\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line WGS FASTQ Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"Whole genome sequencing (WGS) raw data (FASTQ) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Used for deep genomic characterization. Part of a study published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"genomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"FASTQ\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Whole genome sequencing\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"MPNST Cell Line Whole Genome Sequencing\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line Methylation IDAT Files\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"Methylation array data (IDAT files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a deep characterization study assessing genomic/epigenomic profiles and potential misdiagnoses. Published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"methylation array\",\n      \"epigenomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"IDAT\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Epigenomics\",\n      \"DNA methylation\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"Methylation Data from MPNST Cell Line Characterization\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line SNP Microarray Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"SNP array data for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Used for deep genomic characterization and assessment of potential misdiagnoses. Part of a study published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"SNP array\",\n      \"genomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"copy number variation\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Single nucleotide polymorphisms\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"SNP Array Data from MPNST Cell Line Characterization\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line WES Raw Reads\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"Whole exome sequencing (WES) raw data (FASTQ) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a deep characterization study assessing genomic profiles and potential misdiagnoses. Published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"whole exome sequencing\",\n      \"WES\",\n      \"genomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"FASTQ\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Exome sequencing\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"Whole Exome Sequencing Data from MPNST Cell Line Characterization\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"MPNST Cell Line WGS Raw Reads\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n      \"Magall√≥n-Lorenz M\",\n      \"Gel B\",\n      \"Castro S\",\n      \"Vidal A\",\n      \"Torres Martin M\",\n      \"Mart√≠nez A\",\n      \"Serra E\",\n      \"L√≥pez-Almaraz R\",\n      \"P√©rez-Salvia M\",\n      \"Blanco I\",\n      \"Benavente Y\",\n      \"L√°zaro C\"\n    ],\n    \"creator\": [\n      \"Bernat Gel Moreno\",\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1674172800,\n    \"description\": \"Whole genome sequencing (WGS) raw data (FASTQ) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a deep characterization study assessing genomic profiles and potential misdiagnoses. Published in iScience (2023).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"keywords\": [\n      \"MPNST\",\n      \"cell line\",\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"genomics\",\n      \"Neurofibromatosis Type 1\",\n      \"sarcoma\",\n      \"melanoma\",\n      \"misdiagnosis\",\n      \"FASTQ\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 8,\n    \"studyId\": \"syn22392179\",\n    \"subject\": [\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Whole genome sequencing\",\n      \"Neurofibromatosis Type 1\"\n    ],\n    \"title\": \"Whole Genome Sequencing Data from MPNST Cell Line Characterization\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 1368,
            "endIndex": 1514,
            "uri": "https://www.ctf.org/news/women-researchers-in-neurofibromatosis-nf-conxi-lazaro/",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7896,
    "candidatesTokenCount": 4781,
    "totalTokenCount": 12677,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7896
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn22392179"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Drug Target Explorer Database v4\",\n    \"alternateName\": \"Drug Target Explorer\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"contributor\": [\n      \"ChEMBL\",\n      \"ChemicalProbes.org\",\n      \"DGIdb\",\n      \"DrugBank\",\n      \"Klaeger, et al, 2017\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC-BY-SA\",\n    \"keywords\": [\n      \"drug discovery\",\n      \"oncology\",\n      \"drug target interactions\",\n      \"cheminformatics\",\n      \"bioinformatics\",\n      \"database\",\n      \"polypharmacology\",\n      \"chemical probes\",\n      \"ChEMBL\",\n      \"DGIdb\",\n      \"DrugBank\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn11672851\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"A database consolidating drug-target interaction data from ChEMBL, ChemicalProbes.org, DGIdb, DrugBank, and Klaeger et al. (2017). Contains over 280,000 molecules annotated with names, structures, targets (protein/gene IDs), and quantitative pChEMBL values where available. Supports chemical structure and name-based queries for drug discovery research, particularly in oncology.\",\n    \"datePublished\": 1615490610000,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Drug targeting\",\n      \"Cheminformatics\",\n      \"Bioinformatics\",\n      \"Databases\",\n      \"Oncology--Research\",\n      \"Pharmacology\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"visualizeDataOn\": [\n      \"https://shiny.synapse.org/users/rallaway/polypharmacology-db/\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6103,
    "candidatesTokenCount": 528,
    "totalTokenCount": 6631,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6103
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11672851"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"IHC Quantification Data for NF1 MPNST Mouse Models\",\n    \"creator\": [\n      \"Bandarigoda Nipunika Somatilaka\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"Quantification\",\n      \"MPNST\",\n      \"Neurofibromatosis Type 1\",\n      \"Mus musculus\",\n      \"Tumor Microenvironment\",\n      \"STING pathway\",\n      \"Immune Checkpoint Blockers\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn37861830\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"IHC Quantification\",\n    \"contributor\": [\n      \"Anh Nguyet Vu\",\n      \"Bandarigoda Nipunika Somatilaka\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Immunohistochemistry (IHC) quantification data for Malignant Peripheral Nerve Sheath Tumor (MPNST) models from the study 'From cold to hot - Reprogramming tumor microenvironment to target NF1 malignancies'.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Immunohistochemistry\",\n      \"Mice\",\n      \"Tumor Microenvironment\",\n      \"Immunotherapy\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5460,
    "candidatesTokenCount": 473,
    "totalTokenCount": 5933,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5460
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn37861830"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Whole Exome Sequencing Data for NF1 Plexiform Neurofibroma Cell Lines (To Process)\",\n    \"creator\": [\n      \"Peggy Wallace\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\",\n      \"Xindi Guo\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Plexiform Neurofibroma\",\n      \"Whole Exome Sequencing\",\n      \"WES\",\n      \"Cell Line\",\n      \"BAM\",\n      \"Aligned Reads\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw whole exome sequencing alignment data (BAM files) for NF1 plexiform neurofibroma cell lines, pending processing. Generated as part of the Peggy Wallace NF1 cell line project.\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Plexiform Neurofibromas\",\n      \"Cell Line\",\n      \"Whole Exome Sequencing\"\n    ]\n  },\n  {\n    \"title\": \"RNA-seq Gene Quantification (Kallisto) for Selected NF1 Plexiform Neurofibroma Cell Lines\",\n    \"creator\": [\n      \"Peggy Wallace\"\n    ],\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Plexiform Neurofibroma\",\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Kallisto\",\n      \"Cell Line\",\n      \"Quantification\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Kallisto quantified gene expression data (TSV format) derived from RNA sequencing of selected NF1 plexiform neurofibroma cell lines from the Peggy Wallace NF1 cell line project.\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Plexiform Neurofibromas\",\n      \"Cell Line\",\n      \"RNA-Seq\",\n      \"Gene Expression\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data for NF1 Plexiform Neurofibroma Cell Lines\",\n    \"creator\": [\n      \"Peggy Wallace\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Plexiform Neurofibroma\",\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Cell Line\",\n      \"FASTQ\",\n      \"Raw Data\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939874\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw paired-end RNA sequencing data (FASTQ format) from 11 human plexiform neurofibroma cell lines and controls, generated as part of the Peggy Wallace NF1 cell line project.\",\n    \"individualCount\": 11,\n    \"specimenCount\": 11,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Plexiform Neurofibromas\",\n      \"Cell Line\",\n      \"RNA-Seq\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5846,
    "candidatesTokenCount": 1224,
    "totalTokenCount": 7070,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5846
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939874"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"ATP hydrolisis rate\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"ATPase\",\n      \"Hydrolysis\",\n      \"TRAP1\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"ATPase activity assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring ATP hydrolysis rates, likely related to TRAP1 activity in NF1 context.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Calcium Retention Capacity (CRC)\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Calcium Retention Capacity\",\n      \"CRC\",\n      \"Mitochondria\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"calcium retention capacity assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring mitochondrial calcium retention capacity (CRC) in cells relevant to NF1.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"NADH dehydrogenase activity\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NADH dehydrogenase\",\n      \"Complex I\",\n      \"Mitochondria\",\n      \"Metabolism\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring NADH dehydrogenase (Complex I) activity, likely in an NF1 context.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR)\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Oxygen Consumption Rate\",\n      \"OCR\",\n      \"Extracellular Acidification Rate\",\n      \"ECAR\",\n      \"Seahorse\",\n      \"Metabolism\",\n      \"Mitochondria\",\n      \"Glycolysis\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Danio rerio\"\n    ],\n    \"measurementTechnique\": [\n      \"oxygen consumption assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset containing Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) measurements from Seahorse assays in Homo sapiens and Danio rerio models relevant to NF1.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Sorbitol Dehydrogenase (SDH) activity\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Sorbitol Dehydrogenase\",\n      \"SDH\",\n      \"TRAP1 inhibitors\",\n      \"Metabolism\",\n      \"Neurofibromatosis 1\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\",\n      \"Danio rerio\"\n    ],\n    \"measurementTechnique\": [\n      \"sorbitol dehydrogenase activity level assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring Sorbitol Dehydrogenase (SDH) activity in response to TRAP1 inhibitors across Homo sapiens, Mus musculus, and Danio rerio NF1 and MPNST models. Includes aggregated data and images.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"SDS-PAGE and Blue Native PAGE (BN-PAGE) Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"SDS-PAGE\",\n      \"Blue Native PAGE\",\n      \"BN-PAGE\",\n      \"Immunoprecipitation\",\n      \"Gel Filtration\",\n      \"Protein Complex\",\n      \"TRAP1\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"blue native PAGE\",\n      \"gel filtration chromatography\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset containing results from Blue Native PAGE (BN-PAGE) and gel filtration chromatography, likely investigating protein complexes involving TRAP1 in an NF1 context.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Split GFP Assay Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Split GFP\",\n      \"Protein Interaction\",\n      \"Immunoprecipitation\",\n      \"TRAP1\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"reporter gene assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset from Split GFP assays, likely investigating protein-protein interactions related to TRAP1 in Mus musculus models.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"TRAP1-HSP90 ATPase activity\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"ATPase\",\n      \"TRAP1\",\n      \"HSP90\",\n      \"Drug Screen\",\n      \"TRAP1 inhibitors\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"measurementTechnique\": [\n      \"ATPase activity assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring ATPase activity of TRAP1 and HSP90, potentially in the presence of inhibitors. Includes aggregated data and images.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Cell Proliferation Assay Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Cell Proliferation\",\n      \"TRAP1 inhibitors\",\n      \"Drug Response\",\n      \"Neurofibromatosis 1\",\n      \"MPNST\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"cell proliferation\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring cell proliferation in Mus musculus models relevant to NF1 (PN, MPNST) in response to TRAP1 inhibitors. Includes aggregated data and images.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Cell Viability Assay Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Cell Viability\",\n      \"TRAP1 inhibitors\",\n      \"Drug Response\",\n      \"Hypoxia\",\n      \"Normoxia\",\n      \"Neurofibromatosis 1\",\n      \"MPNST\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring cell viability in Mus musculus models relevant to NF1 (PN, MPNST) under different conditions (e.g., hypoxia) and treatments (TRAP1 inhibitors). Includes aggregated data and images.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Compound List\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Chemical Compounds\",\n      \"TRAP1 inhibitors\",\n      \"Honokiol\",\n      \"Drug Discovery\"\n    ],\n    \"dataType\": [\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"List and structures of chemical compounds, including TRAP1 inhibitors like Honokiol bis-dichloroacetate (HDCA), used in the study.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Fluorescence Microscopy Images\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Microscopy\",\n      \"Fluorescence Microscopy\",\n      \"Imaging\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"fluorescence microscopy\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset containing fluorescence microscopy images from Mus musculus models relevant to NF1.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Immunohistochemistry (IHC) Images\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"Imaging\",\n      \"Biomarkers\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset containing immunohistochemistry (IHC) images, likely from tissues relevant to NF1 research.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"In Vitro Interaction Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"In Vitro\",\n      \"Protein Interaction\",\n      \"Binding Assay\",\n      \"Biacore\",\n      \"TRAP1\",\n      \"Neurofibromatosis 1\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset describing in vitro interaction studies, possibly using Biacore, involving Homo sapiens proteins relevant to NF1.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"In Vitro Tumorigenesis Assay Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"In Vitro Tumorigenesis\",\n      \"Focus Forming Assay\",\n      \"Matrigel\",\n      \"TRAP1 inhibitors\",\n      \"Drug Response\",\n      \"Neurofibromatosis 1\",\n      \"MPNST\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"image\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"focus forming assay\",\n      \"in vitro tumorigenesis\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset from in vitro tumorigenesis assays (focus forming, Matrigel) using Mus musculus models relevant to NF1/MPNST, testing effects of TRAP1 inhibitors. Includes aggregated data and images.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"In Vivo Tumorigenesis Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"In Vivo Tumorigenesis\",\n      \"Tumor Growth\",\n      \"Xenograft\",\n      \"Mouse Model\",\n      \"MPNST\",\n      \"TRAP1\",\n      \"SIRT3\",\n      \"Neurofibromatosis 1\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"in vivo tumor growth\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset containing in vivo tumor growth data from Mus musculus models (e.g., sMPNST xenografts), investigating factors like TRAP1 and SIRT3 in NF1/MPNST context.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Mass Spectrometry Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Mass Spectrometry\",\n      \"Metabolomics\",\n      \"NAD\",\n      \"NADH\",\n      \"TRAP1\",\n      \"Neurofibromatosis 1\",\n      \"Plexiform Neurofibroma\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"mass spectrometry\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Mass spectrometry dataset, likely measuring metabolites (e.g., NAD+/NADH) in Homo sapiens samples relevant to NF1 (PN, MPNST).\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Mitochondrial Reactive Oxygen Species (ROS) Data\",\n    \"creator\": [\n      \"Andrea Rasola\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Reactive Oxygen Species\",\n      \"ROS\",\n      \"Mitochondria\",\n      \"Honokiol\",\n      \"TRAP1\",\n      \"Neurofibromatosis 1\",\n      \"Plexiform Neurofibroma\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn8016650\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Andrea Rasola\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"reactive oxygen species assay\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Dataset measuring mitochondrial reactive oxygen species (ROS) levels in Mus musculus models relevant to NF1 (PN, MPNST), potentially under treatment conditions (e.g., Honokiol).\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 8064,
    "candidatesTokenCount": 5663,
    "totalTokenCount": 13727,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 8064
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn8016650"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Synodos NF1 Patient WES Data (GSE145064)\",\n    \"creator\": [\n      \"Yi-Mi Wu\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"Homo sapiens\",\n      \"GSE145064\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn5610418\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"GSE145064\",\n    \"contributor\": [],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Gene expression data derived from RNA sequencing of samples from 15 individuals with Neurofibromatosis type 1. Includes Plexiform Neurofibroma and Malignant Peripheral Nerve Sheath Tumor samples. Data corresponds to GEO accession GSE145064.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 15,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 46,\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Gene Expression\",\n      \"RNA-Seq\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5196,
    "candidatesTokenCount": 469,
    "totalTokenCount": 5665,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5196
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn5610418"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Kinome Data from NF1-deficient Schwann Cells\",\n    \"creator\": [\n      \"James Walker, Ph.D.\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"kinomics\",\n      \"MIB/MS\",\n      \"mass spectrometry\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cells\",\n      \"plexiform neurofibroma\",\n      \"signaling networks\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Kinome data generated using Multiplexed Inhibitor Beads and Mass Spectrometry (MIB/MS) analysis of NF1-deficient Schwann cells derived from plexiform neurofibromas. Part of a study modeling signaling networks in NF1.\",\n    \"contributor\": [\n      \"Stephanie Bouley\"\n    ],\n    \"measurementTechnique\": [\n      \"MIB/MS\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Schwann Cells\",\n      \"Protein Kinases\",\n      \"Signal Transduction\",\n      \"Plexiform Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data for NF-OSI Processing (Walker NF1 Study)\",\n    \"creator\": [\n      \"James Walker, Ph.D.\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"raw data\",\n      \"gene expression\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cells\",\n      \"plexiform neurofibroma\",\n      \"NF-OSI\",\n      \"FASTQ\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from NF1-deficient Schwann cells, intended for processing via the NF-OSI pipeline. Generated as part of a study modeling signaling networks in NF1 plexiform neurofibromas.\",\n    \"contributor\": [\n      \"Stephanie Bouley\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Schwann Cells\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Plexiform Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Proteomics and Phosphoproteomics Data from NF1-deficient Schwann Cells\",\n    \"creator\": [\n      \"James Walker, Ph.D.\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"phosphoproteomics\",\n      \"TMT quantitation\",\n      \"mass spectrometry\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cells\",\n      \"plexiform neurofibroma\",\n      \"signaling networks\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Total proteome and normalized phosphoproteome data generated using Tandem Mass Tag (TMT) quantitation and mass spectrometry analysis of NF1-deficient Schwann cells derived from plexiform neurofibromas. Part of a study modeling signaling networks in NF1.\",\n    \"contributor\": [\n      \"Stephanie Bouley\"\n    ],\n    \"measurementTechnique\": [\n      \"TMT quantitation\",\n      \"mass spectrometry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Schwann Cells\",\n      \"Proteomics\",\n      \"Phosphoproteins\",\n      \"Signal Transduction\",\n      \"Plexiform Neurofibroma\",\n      \"Mass Spectrometry\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data from NF1 Schwann Cells (Walker Study)\",\n    \"creator\": [\n      \"James Walker, Ph.D.\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"raw data\",\n      \"gene expression\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Schwann cells\",\n      \"plexiform neurofibroma\",\n      \"FASTQ\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn8016599\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from Schwann cells used in a study modeling signaling networks in NF1 plexiform neurofibromas. Includes samples derived from NF1 individuals.\",\n    \"contributor\": [\n      \"Stephanie Bouley\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Schwann Cells\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Plexiform Neurofibroma\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 400,
            "endIndex": 520,
            "uri": "https://www.massgeneral.org/neurology/research/walker-lab-james-walker",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6713,
    "candidatesTokenCount": 1524,
    "totalTokenCount": 8237,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6713
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn8016599"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Copy Number Variant Data using CNVkit\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"copy number variation\",\n      \"CNV\",\n      \"CNVkit\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"MPNST\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"NF Service\"\n    ],\n    \"individualCount\": 0,\n    \"specimenCount\": 0,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Copy number variant data generated using the CNVkit pipeline for Neurofibromatosis Type 1 associated peripheral nerve sheath tumors.\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants identified by DeepVariant Pipeline\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"germline variants\",\n      \"genomic variants\",\n      \"DeepVariant\",\n      \"VCF\",\n      \"whole genome sequencing\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"NF Service\"\n    ],\n    \"individualCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Germline genomic variants in VCF format identified from whole genome sequencing data using the DeepVariant pipeline for Neurofibromatosis Type 1 patients.\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\",\n      \"Cutaneous Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants identified by FreeBayes Pipeline\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"germline variants\",\n      \"genomic variants\",\n      \"FreeBayes\",\n      \"VCF\",\n      \"whole genome sequencing\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"NF Service\"\n    ],\n    \"individualCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Germline genomic variants in VCF format identified from whole genome sequencing data using the FreeBayes pipeline for Neurofibromatosis Type 1 patients.\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\",\n      \"Cutaneous Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants identified by Mutect2 Pipeline\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"germline variants\",\n      \"genomic variants\",\n      \"Mutect2\",\n      \"VCF\",\n      \"whole genome sequencing\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"NF Service\"\n    ],\n    \"individualCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Germline genomic variants in VCF format identified from whole genome sequencing data using the Mutect2 pipeline for Neurofibromatosis Type 1 patients.\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\",\n      \"Cutaneous Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants identified by Strelka Pipeline\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"germline variants\",\n      \"genomic variants\",\n      \"Strelka\",\n      \"VCF\",\n      \"whole genome sequencing\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"NF Service\"\n    ],\n    \"individualCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Germline genomic variants in VCF format identified from whole genome sequencing data using the Strelka pipeline for Neurofibromatosis Type 1 patients.\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\",\n      \"Cutaneous Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Metadata for Methylation Array Data\",\n    \"creator\": [\n      \"Benjamin Johnson\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"metadata\",\n      \"methylation array\",\n      \"epigenetics\",\n      \"chromatin activity\",\n      \"Neurofibromatosis type 1\",\n      \"cutaneous neurofibroma\"\n    ],\n    \"dataType\": [\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"Benjamin Johnson\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Metadata file describing samples used in the methylation array analysis of cutaneous neurofibromas in Neurofibromatosis Type 1.\"\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data for Processing (March 2023)\",\n    \"creator\": [\n      \"Steven Angus\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA sequencing\",\n      \"transcriptomics\",\n      \"FASTQ\",\n      \"raw data\",\n      \"Neurofibromatosis type 1\",\n      \"MPNST\",\n      \"plexiform neurofibroma\",\n      \"cutaneous neurofibroma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"Steven Angus\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from Neurofibromatosis Type 1 related samples, submitted for processing in March 2023.\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\",\n      \"Cutaneous Neurofibroma\"\n    ]\n  },\n  {\n    \"title\": \"Raw Whole Genome Sequencing Data (April 2022)\",\n    \"creator\": [\n      \"Matthew R. Steensma, M.D.\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole genome sequencing\",\n      \"genomics\",\n      \"FASTQ\",\n      \"raw data\",\n      \"Neurofibromatosis type 1\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\"\n    ],\n    \"individualCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"description\": \"Raw whole genome sequencing data (FASTQ format) from individuals with Neurofibromatosis Type 1 and plexiform neurofibromas, submitted for processing in April 2022.\"\n  },\n  {\n    \"title\": \"Processed Methylation Beta Value Matrix\",\n    \"creator\": [\n      \"Benjamin Johnson\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"methylation array\",\n      \"beta values\",\n      \"processed data\",\n      \"epigenetics\",\n      \"chromatin activity\",\n      \"Neurofibromatosis type 1\",\n      \"cutaneous neurofibroma\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"Benjamin Johnson\",\n      \"Sara Gosline\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"description\": \"Processed methylation beta value matrix derived from EPIC array data, comparing cutaneous and plexiform neurofibromas in Neurofibromatosis Type 1.\"\n  },\n  {\n    \"title\": \"Raw Methylation Array Data (EPIC iDAT) for CNF and PNF\",\n    \"creator\": [\n      \"Benjamin Johnson\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"methylation array\",\n      \"EPIC array\",\n      \"iDAT\",\n      \"raw data\",\n      \"epigenetics\",\n      \"chromatin activity\",\n      \"Neurofibromatosis type 1\",\n      \"cutaneous neurofibroma\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\",\n      \"RawIntensities\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"Benjamin Johnson\"\n    ],\n    \"individualCount\": 38,\n    \"specimenCount\": 60,\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"description\": \"Raw intensity data (iDAT format) from Illumina EPIC methylation arrays profiling cutaneous and plexiform neurofibromas from individuals with Neurofibromatosis Type 1.\"\n  },\n  {\n    \"title\": \"RNA Sequencing and Whole Exome Sequencing Data Manifest\",\n    \"creator\": [\n      \"Steven Angus\",\n      \"Matthew R. Steensma, M.D.\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA sequencing\",\n      \"whole exome sequencing\",\n      \"transcriptomics\",\n      \"genomics\",\n      \"FASTQ\",\n      \"manifest\",\n      \"Neurofibromatosis type 1\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"genomicVariants\",\n      \"clinical\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"Steven Angus\"\n    ],\n    \"individualCount\": 9,\n    \"specimenCount\": 11,\n    \"measurementTechnique\": [\n      \"RNA-seq\",\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"description\": \"Manifest file and associated raw data (FASTQ) for RNA sequencing and whole exome sequencing of plexiform neurofibroma samples from Neurofibromatosis Type 1 patients.\"\n  },\n  {\n    \"title\": \"Whole Exome Sequencing of NF1 Mouse Model Samples\",\n    \"creator\": [\n      \"Megan Bowman\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole exome sequencing\",\n      \"genomics\",\n      \"FASTQ\",\n      \"mouse model\",\n      \"Neurofibromatosis type 1\",\n      \"malignant peripheral nerve sheath tumor\",\n      \"MPNST\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4939910\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Matthew R. Steensma, M.D.\",\n      \"Megan Bowman\"\n    ],\n    \"individualCount\": 2,\n    \"specimenCount\": 7,\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"description\": \"Raw whole exome sequencing data (FASTQ format) from a Neurofibromatosis Type 1 mouse model exhibiting Malignant Peripheral Nerve Sheath Tumors (MPNST).\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 8225,
    "candidatesTokenCount": 4004,
    "totalTokenCount": 12229,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 8225
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939910"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"12 month deliverables - WES data from cutaneous neurofibroma cells\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"whole exome sequencing\",\n      \"WES\",\n      \"genomic variants\",\n      \"fibroblast\",\n      \"Schwann cell\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 10,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Whole exome sequencing data generated from primary Schwann cells and fibroblasts derived from cutaneous neurofibromas of NF1 patients. Part of the 12-month deliverables.\"\n  },\n  {\n    \"title\": \"18 month deliverables - RNA-seq data from cNF cultures\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"fibroblast\",\n      \"Schwann cell\",\n      \"co-culture\",\n      \"primary culture\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Christina Parry\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"RNA sequencing data from cutaneous neurofibromas, primary Schwann cell cultures, primary fibroblast cultures, and co-cultures of Schwann cells and fibroblasts from NF1 patients. Part of the 18-month deliverables.\"\n  },\n  {\n    \"title\": \"24 month deliverables - Co-culture analysis data\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"co-culture\",\n      \"fibroblast\",\n      \"Schwann cell\",\n      \"analysis\",\n      \"gene expression signature\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Analysis results from Schwann cell and fibroblast co-culture experiments related to cutaneous neurofibromas in NF1 patients. Part of the 24-month deliverables.\"\n  },\n  {\n    \"title\": \"36 month deliverables - Functional assay data\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Luminex\",\n      \"immunoassay\",\n      \"proliferation assay\",\n      \"EdU\",\n      \"co-culture\",\n      \"fibroblast\",\n      \"Schwann cell\",\n      \"functional assay\"\n    ],\n    \"dataType\": [\n      \"immunoassay\",\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Helena Mazuelas\"\n    ],\n    \"measurementTechnique\": [\n      \"immunoassay\",\n      \"EdU proliferation assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Functional assay data including Luminex immunoassay results and EdU cell proliferation assays for Schwann cell and fibroblast cultures and co-cultures from NF1 patients. Part of the 36-month deliverables.\"\n  },\n  {\n    \"title\": \"6 month deliverables - Mutation analysis results\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"mutation analysis\",\n      \"genomic variants\",\n      \"WES\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Mutation analysis results derived from whole exome sequencing of cutaneous neurofibroma samples from NF1 patients. Part of the 6-month deliverables.\"\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"quantification\",\n      \"fibroblast\",\n      \"Schwann cell\",\n      \"co-culture\",\n      \"primary culture\",\n      \"NF-OSI\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"NF Service\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Processed gene expression quantification data (Salmon format) derived from RNA-seq of cutaneous neurofibromas, primary cultures, and co-cultures from NF1 patients.\",\n    \"series\": \"NF-OSI Processed Data\"\n  },\n  {\n    \"title\": \"NF-OSI Processed RNA-seq Data\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"quantification\",\n      \"aligned reads\",\n      \"BAM\",\n      \"Salmon\",\n      \"NF-OSI\",\n      \"fibroblast\",\n      \"Schwann cell\",\n      \"co-culture\",\n      \"primary culture\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"NF Service\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Processed RNA-sequencing data including aligned reads (BAM) and gene expression quantification (Salmon) generated by the NF-OSI pipeline from NF1 patient samples.\",\n    \"series\": \"NF-OSI Processed Data\"\n  },\n  {\n    \"title\": \"Raw RNA-seq Data for NF-OSI Processing (March 2023)\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"RNA-seq\",\n      \"FASTQ\",\n      \"raw data\",\n      \"fibroblast\",\n      \"Schwann cell\",\n      \"co-culture\",\n      \"primary culture\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 13,\n    \"specimenCount\": 28,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from NF1 patient samples (cutaneous neurofibromas, primary cultures, co-cultures) submitted for NF-OSI processing in March 2023.\"\n  },\n  {\n    \"title\": \"Raw WES Data for NF-OSI Processing (March 2024)\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"cutaneous neurofibroma\",\n      \"cNf\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"whole exome sequencing\",\n      \"WES\",\n      \"FASTQ\",\n      \"raw data\",\n      \"fibroblast\",\n      \"Schwann cell\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11374353\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 10,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Raw whole exome sequencing data (FASTQ format) from NF1 patient samples (cutaneous neurofibroma derived cells) submitted for NF-OSI processing in March 2024.\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6843,
    "candidatesTokenCount": 3085,
    "totalTokenCount": 9928,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6843
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374353"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Bulk RNA Sequencing Donor RGCs\",\n    \"creator\": [\n      \"Michael Young\",\n      \"Petr Baranov\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA Sequencing\",\n      \"Retinal Ganglion Cells\",\n      \"RGC\",\n      \"Stem Cells\",\n      \"Transplantation\",\n      \"Mus musculus\",\n      \"Gene Expression\",\n      \"Aligned Reads\",\n      \"Vision Restoration\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21650484\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"alternateName\": \"RGC RNA-Seq Data\",\n    \"contributor\": [\n      \"Julia Oswald\",\n      \"Christina Parry\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Bulk RNA sequencing data from donor Retinal Ganglion Cells (RGCs) derived from Mus musculus stem cells, generated as part of research to improve RGC transplantation strategies.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 2,\n    \"subject\": [\n      \"Retinal ganglion cells\",\n      \"Stem cells\",\n      \"Cell transplantation\",\n      \"RNA Sequence Analysis\",\n      \"Mice\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 3381,
            "endIndex": 3525,
            "uri": "https://www.ctf.org.au/page/112/schwannomatosis",
            "license": ""
          },
          {
            "startIndex": 3412,
            "endIndex": 3552,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5282,
    "candidatesTokenCount": 381,
    "totalTokenCount": 5663,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5282
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn21650484"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Whole Exome Sequencing Data from NF1+/- and NF1-/- Plexiform Neurofibroma-Derived Tumor Cells and iPSCs\",\n    \"alternateName\": \"syn64954703\",\n    \"description\": \"Whole exome sequencing data from plexiform neurofibroma (pNF) tumor samples and derived induced pluripotent stem cells (iPSCs) from individuals with Neurofibromatosis type 1 (NF1). Generated to study genomic variation.\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Plexiform Neurofibroma\",\n      \"PNF\",\n      \"induced pluripotent stem cells\",\n      \"iPSC\",\n      \"whole exome sequencing\",\n      \"WES\",\n      \"genomic variants\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 9,\n    \"specimenCount\": 35,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Raw WES Data for NFOSI Processing from NF1 PNF Samples (syn51200209)\",\n    \"alternateName\": \"syn51200209\",\n    \"description\": \"Raw Whole Exome Sequencing (WES) data (FASTQ, BAI) from Neurofibromatosis type 1 plexiform neurofibroma samples, intended for NFOSI processing pipeline. Part of the study exploring NF1 genomic variation.\",\n    \"creator\": [\n      \"Bernat Gel Moreno\"\n    ],\n    \"contributor\": [\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Plexiform Neurofibroma\",\n      \"PNF\",\n      \"WES\",\n      \"raw data\",\n      \"FASTQ\",\n      \"BAI\",\n      \"NFOSI\",\n      \"processing\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"SNP Array Data from NF1+/- and NF1-/- Plexiform Neurofibroma-Derived Tumor Cells and iPSCs\",\n    \"alternateName\": \"syn64954704\",\n    \"description\": \"SNP array data from plexiform neurofibroma (pNF) tumor samples and derived induced pluripotent stem cells (iPSCs) from individuals with Neurofibromatosis type 1 (NF1). Generated to study genomic variation.\",\n    \"creator\": [\n      \"Eduard Serra\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Eduard Serra\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Plexiform Neurofibroma\",\n      \"PNF\",\n      \"induced pluripotent stem cells\",\n      \"iPSC\",\n      \"SNP array\",\n      \"genomic variants\",\n      \"copy number variation\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"studyId\": \"syn7231973\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 23,\n    \"specimenCount\": 40,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5613,
    "candidatesTokenCount": 1195,
    "totalTokenCount": 6808,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5613
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn7231973"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Copy Number Variant Data from CNVkit Analysis of Plasma cfDNA WGS\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"copy number variation\",\n      \"CNV\",\n      \"CNVkit\",\n      \"Neurofibromatosis type 1\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Plexiform Neurofibroma\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\",\n      \"genomicFeatures\",\n      \"image\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\",\n      \"NF Service\"\n    ],\n    \"description\": \"Copy number variant calls generated using CNVkit from ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) from NF1 patients with Malignant Peripheral Nerve Sheath Tumor (MPNST) or Plexiform Neurofibroma (PN). Includes .cnr, .cns, .bed, and scatter plot files.\",\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"DNA Copy Number Variations\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants from DeepVariant Analysis of Plasma cfDNA WGS\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"genomic variants\",\n      \"germline variants\",\n      \"VCF\",\n      \"DeepVariant\",\n      \"Neurofibromatosis type 1\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\",\n      \"NF Service\"\n    ],\n    \"description\": \"Germline genomic variants (VCF format) identified using the DeepVariant pipeline from ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) from NF1 patients. Derived from aligned reads in syn31726450.\",\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"Germ-Line Mutation\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants from FreeBayes Analysis of Plasma cfDNA WGS\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"genomic variants\",\n      \"germline variants\",\n      \"VCF\",\n      \"FreeBayes\",\n      \"Neurofibromatosis type 1\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\",\n      \"NF Service\"\n    ],\n    \"description\": \"Germline genomic variants (VCF format) identified using the FreeBayes pipeline from ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) from NF1 patients. Derived from aligned reads in syn31726450.\",\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"Germ-Line Mutation\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants from Mutect2 Analysis of Plasma cfDNA WGS\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"genomic variants\",\n      \"germline variants\",\n      \"VCF\",\n      \"Mutect2\",\n      \"GATK\",\n      \"Neurofibromatosis type 1\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\",\n      \"NF Service\"\n    ],\n    \"description\": \"Germline genomic variants (VCF format) identified using the GATK Mutect2 pipeline from ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) from NF1 patients. Derived from aligned reads in syn31726450.\",\n    \"individualCount\": 42,\n    \"specimenCount\": 90,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"Germ-Line Mutation\"\n    ]\n  },\n  {\n    \"title\": \"Germline Genomic Variants from Strelka Analysis of Plasma cfDNA WGS\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"genomic variants\",\n      \"germline variants\",\n      \"VCF\",\n      \"Strelka\",\n      \"Neurofibromatosis type 1\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\",\n      \"NF Service\"\n    ],\n    \"description\": \"Germline genomic variants (VCF format) identified using the Strelka pipeline from ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) from NF1 patients. Derived from aligned reads in syn31726450.\",\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"Germ-Line Mutation\"\n    ]\n  },\n  {\n    \"title\": \"Processed ULP-WGS Alignment Data (BAM files) - NF-OSI 2022\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"alignment\",\n      \"BAM\",\n      \"Neurofibromatosis type 1\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\",\n      \"processed data\",\n      \"NF-OSI\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\"\n    ],\n    \"description\": \"Processed ultra-low-pass whole genome sequencing (ULP-WGS) alignment data (BAM format) for plasma cell-free DNA (cfDNA) from NF1 patients with MPNST or PN. Processed in 2022 as part of the NF-OSI initiative.\",\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"series\": \"NF-OSI Processed Data\",\n    \"yearProcessed\": 2022,\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"Sequence Alignment\"\n    ]\n  },\n  {\n    \"title\": \"ULP Whole Genome Sequencing Data for NF1 MPNST/PN cfDNA Study\",\n    \"creator\": [\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PN\",\n      \"ULP-WGS\",\n      \"cfDNA\",\n      \"liquid biopsy\",\n      \"alignment\",\n      \"BAM\",\n      \"genomic variants\",\n      \"clinical data\",\n      \"metadata\",\n      \"Neurofibromatosis type 1\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Plexiform Neurofibroma\",\n      \"cell-free DNA\",\n      \"whole genome sequencing\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\",\n      \"clinical\",\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn23651229\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"contributor\": [\n      \"National Cancer Institute - Pediatric Oncology Branch\",\n      \"Washington University in St Louis\",\n      \"Jack Shern\",\n      \"Angela Hirbe\",\n      \"Aadel Chaudhuri\",\n      \"R. Taylor Sundby\",\n      \"Jeff Szymanski\"\n    ],\n    \"description\": \"Comprehensive dataset including clinical metadata, aligned reads (BAM), and genomic variants from the ultra-low-pass whole genome sequencing (ULP-WGS) study of plasma cell-free DNA (cfDNA) comparing NF1 patients with MPNST and PN.\",\n    \"individualCount\": 59,\n    \"specimenCount\": 117,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Plexiform Neurofibroma\",\n      \"Cell-Free Nucleic Acids\",\n      \"Whole Genome Sequencing\",\n      \"Sequence Alignment\",\n      \"Clinical Data\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 486,
            "endIndex": 627,
            "uri": "https://www.synapse.org/#!Synapse:syn23651229",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6548,
    "candidatesTokenCount": 4226,
    "totalTokenCount": 10774,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6548
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn23651229"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Controlled Access\",\n    \"contributor\": [\n      \"Sue Rathe\",\n      \"Jon Hawkinson\",\n      \"Kyle Williams\",\n      \"Mike Mason\",\n      \"Robert Allaway\",\n      \"Nasim Sanati\",\n      \"Sara Gosline\"\n    ],\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"drugScreen\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Data generated by the Minnesota, CCHMC, and Recombinetics Synodos NF1 team, including MRI images, RNA-seq data, and cell viability assays from Sus scrofa and Homo sapiens models focusing on NF1 plexiform neurofibroma and MPNST.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 20,\n    \"keywords\": [\n      \"Synodos\",\n      \"NF1\",\n      \"Preclinical Models\",\n      \"Sus scrofa\",\n      \"Homo sapiens\",\n      \"MRI\",\n      \"RNA-seq\",\n      \"Cell Viability\",\n      \"Plexiform Neurofibroma\",\n      \"MPNST\",\n      \"Minnesota\",\n      \"CCHMC\",\n      \"Recombinetics\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"conventional MRI\",\n      \"RNA-seq\",\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Sus scrofa\",\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 21,\n    \"studyId\": \"syn52740594\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Animal models\",\n      \"Swine\",\n      \"Magnetic resonance imaging\",\n      \"RNA sequencing\",\n      \"Drug screening\",\n      \"Plexiform neurofibromas\",\n      \"Malignant peripheral nerve sheath tumors\"\n    ],\n    \"title\": \"Minnesota CCHMC Recombinetics Team Data\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5119,
    "candidatesTokenCount": 580,
    "totalTokenCount": 5699,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5119
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn52740594"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"Optical Dopamine Monitoring with dLight1 in NF1 Model Mice\",\n    \"contributor\": [\n      \"J. Elliott Robinson\",\n      \"Gerard M. Coughlin\",\n      \"Acacia M. Hori\",\n      \"Elisha D. Mackey\",\n      \"Jounhong Ryan Cho\",\n      \"Zeynep Turan\",\n      \"Tommaso Patriarchi\",\n      \"Lin Tian\"\n    ],\n    \"creator\": [\n      \"Viviana Gradinaru\"\n    ],\n    \"dataType\": [\n      \"behavior process\",\n      \"electrophysiology\",\n      \"immunoassay\",\n      \"proteomics\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Behavioral, electrophysiological, immunoassay, and proteomic data from a study using dLight1 to monitor dopamine in the ventral striatum of NF1 model mice, exploring dopaminergic circuit function and morphology.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\",\n      \"NIH-NCI\",\n      \"Other\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"dopamine\",\n      \"dLight1\",\n      \"mesolimbic\",\n      \"ventral striatum\",\n      \"mouse model\",\n      \"neurodevelopmental disorder\",\n      \"behavior\",\n      \"electrophysiology\",\n      \"immunoassay\",\n      \"proteomics\",\n      \"AAV\",\n      \"tissue clearing\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Behavioral\",\n      \"Cognition\"\n    ],\n    \"measurementTechnique\": [\n      \"contextual conditioning behavior assay\",\n      \"in vivo bioluminescence\",\n      \"whole-cell patch clamp\",\n      \"immunofluorescence\",\n      \"liquid chromatography-electrochemical detection\",\n      \"active avoidance learning behavior assay\",\n      \"novelty response behavior assay\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"studyId\": \"syn18904024\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Mice--Models\",\n      \"Dopamine\",\n      \"Ventral Striatum\",\n      \"Neurophysiology\",\n      \"Behavior, Animal\",\n      \"Optogenetics\"\n    ],\n    \"title\": \"Optical Dopamine Monitoring with dLight1 in NF1 Model Mice\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 3697,
            "endIndex": 3959,
            "uri": "https://www.synapse.org/Synapse:syn18904024",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5285,
    "candidatesTokenCount": 635,
    "totalTokenCount": 5920,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5285
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn18904024"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"20201125-ipNF0.23 and ipnF05.5 O-glycosylation\",\n    \"creator\": [\n      \"Kevin Bruemmer\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"glycosylation\",\n      \"O-glycosylation\",\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"mass spectrometry\",\n      \"cell line\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Kevin Bruemmer\",\n      \"Anh Nguyet Vu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 2,\n    \"measurementTechnique\": [\n      \"mass spectrometry\"\n    ],\n    \"description\": \"Proteomic data characterizing O-glycosylation in ipNF0.23 and ipnF05.5 cell lines related to Neurofibromatosis type 1 (NF1).\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"NF1 Proteomics\",\n    \"creator\": [\n      \"Kevin Bruemmer\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"mass spectrometry\",\n      \"cell line\",\n      \"Ras pathway\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Kevin Bruemmer\",\n      \"Anh Nguyet Vu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 2,\n    \"measurementTechnique\": [\n      \"mass spectrometry\"\n    ],\n    \"description\": \"Raw proteomics data from Neurofibromatosis type 1 (NF1) cell lines generated using mass spectrometry.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Neurofibromin Immunoprecipitation 20201123\",\n    \"creator\": [\n      \"Kevin Bruemmer\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"immunoprecipitation\",\n      \"IP\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"mass spectrometry\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn22267284\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Kevin Bruemmer\",\n      \"Anh Nguyet Vu\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 1,\n    \"measurementTechnique\": [\n      \"mass spectrometry\",\n      \"immunoassay\"\n    ],\n    \"description\": \"Proteomic data from Neurofibromin immunoprecipitation experiments, likely related to NF1 research.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5662,
    "candidatesTokenCount": 923,
    "totalTokenCount": 6585,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5662
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn22267284"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"PRO Reports\",\n    \"creator\": [\n      \"Nancy Swigonski\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Patient Reported Outcomes\",\n      \"PRO\",\n      \"Quality of Life\",\n      \"PedsQL\",\n      \"Questionnaire\",\n      \"Survey\"\n    ],\n    \"dataType\": [\n      \"surveyData\"\n    ],\n    \"studyId\": \"syn4939878\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Survey data from the development and testing of the child self-report and parent proxy-report versions of the Pediatric Quality of Life Inventory (PedsQL) Neurofibromatosis Type 1 (NF1) module for pediatric patients ages 5-25.\",\n    \"measurementTechnique\": [\n      \"questionnaire\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Quality of Life\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Kavitha Nutakki\",\n      \"Sara Gosline\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"alternateName\": \"PedsQL NF1 Module Data\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Quality of life -- Patients\",\n      \"Patient-reported outcome measures\",\n      \"Children -- Health and hygiene\",\n      \"Parents -- Attitudes\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 738,
            "endIndex": 905,
            "uri": "https://www.n-tap.org/for-researchers/index-of-funded-nf1-initiatives-research",
            "license": ""
          },
          {
            "startIndex": 934,
            "endIndex": 1107,
            "uri": "https://www.synapse.org/#!Synapse:syn4939878/wiki/235895",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5482,
    "candidatesTokenCount": 442,
    "totalTokenCount": 5924,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5482
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939878"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"NF-OSI Processed Data - MPNST Novel Therapeutics Study FastQC Reports\",\n    \"alternateName\": \"syn64954766\",\n    \"creator\": [\n      \"NF Service\"\n    ],\n    \"contributor\": [\n      \"Ping Chi\",\n      \"NF Service\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"RNA sequencing\",\n      \"Quality Control\",\n      \"FastQC\",\n      \"processed data\",\n      \"NF-OSI\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"dataIndex\"\n    ],\n    \"studyId\": \"syn11681835\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Quality control reports (FastQC) for RNA sequencing data generated as part of the MPNST novel therapeutics study. This processed data aids in assessing the quality of the raw sequence reads.\",\n    \"series\": \"NF-OSI Processed Data\"\n  },\n  {\n    \"title\": \"Raw RNA-Seq and scRNA-Seq Data for MPNST Novel Therapeutics Study\",\n    \"alternateName\": \"NFOSI-RNASeq-To-Process-2023-14-03\",\n    \"creator\": [\n      \"Christina Parry\"\n    ],\n    \"contributor\": [\n      \"Ping Chi\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"RNA sequencing\",\n      \"single-cell RNA sequencing\",\n      \"gene expression\",\n      \"raw sequence data\",\n      \"FASTQ\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"studyId\": \"syn11681835\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 41,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\",\n      \"single-cell RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 41,\n    \"description\": \"Raw RNA sequencing (RNA-seq) and single-cell RNA sequencing (scRNA-seq) data (FASTQ) from 41 Malignant Peripheral Nerve Sheath Tumor (MPNST) specimens from individuals with Neurofibromatosis Type 1. Data generated to support investigation of novel therapeutics.\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6384,
    "candidatesTokenCount": 796,
    "totalTokenCount": 7180,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6384
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11681835"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Trial Run HscWT and Hsc45 Proteomics\",\n    \"creator\": [\n      \"Isabelle E. Logan\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"proteomics\",\n      \"phosphoproteomics\",\n      \"schwannoma\",\n      \"merlin\",\n      \"nitrated proteins\",\n      \"Hsp90\",\n      \"signal transduction\",\n      \"trial run\",\n      \"Hsc\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn26238842\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"Hsc Proteomics Trial Run\",\n    \"contributor\": [\n      \"Maria C. Franco\",\n      \"Isabelle E. Logan\",\n      \"Oregon State University\",\n      \"University of Central Florida\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Trial run proteomics and phosphoproteomics data comparing HscWT and Hsc45 cells, generated as part of a study investigating nitrated proteins as therapeutic targets in NF2-related schwannomas.\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"mass spectrometry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Proteomics\",\n      \"Schwannoma\",\n      \"Signal transduction\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5287,
    "candidatesTokenCount": 432,
    "totalTokenCount": 5719,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5287
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn26238842"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"12 Months Deliverable: Immunohistochemistry Images for cNF Organoid Project\",\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\",\n      \"3D Model\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 9,\n    \"specimenCount\": 76,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Immunohistochemistry images generated as part of the 12-month deliverable for the cNF organoid modeling project. Includes images stained for S100, CD34, and CD56.\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ]\n  },\n  {\n    \"title\": \"6 Months Deliverable: Immunohistochemistry Protocols and Images for cNF Organoid Project\",\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"Protocol\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\",\n      \"3D Model\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 1,\n    \"specimenCount\": 2,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Immunohistochemistry protocols (CD56, SOX10, SOX2, NGFR, S100) and related images generated as part of the 6-month deliverable for the cNF organoid modeling project.\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ]\n  },\n  {\n    \"title\": \"Aligned Reads (BAM) from RNA-seq of Cutaneous Neurofibroma Organoid Model\",\n    \"creator\": [\n      \"Orca Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Aligned Reads\",\n      \"BAM\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\",\n      \"Gene Expression\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\",\n      \"dataIndex\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 54,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Processed RNA sequencing data consisting of aligned reads (BAM files) and index files (BAI) derived from the patient-derived cutaneous neurofibroma organoid model.\",\n    \"contributor\": [\n      \"Alice Soragni\",\n      \"Orca Service\"\n    ]\n  },\n  {\n    \"title\": \"Gene Expression Quantification (Salmon) from RNA-seq of Cutaneous Neurofibroma Organoid Model\",\n    \"creator\": [\n      \"Orca Service\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"Quantification\",\n      \"Salmon\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 55,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Gene expression quantification data (Salmon format) generated from RNA sequencing of the patient-derived cutaneous neurofibroma organoid model.\",\n    \"contributor\": [\n      \"Alice Soragni\",\n      \"Orca Service\"\n    ]\n  },\n  {\n    \"title\": \"Raw Bisulfite Sequencing Data (FASTQ) from Cutaneous Neurofibroma Organoid Model\",\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Bisulfite Sequencing\",\n      \"RRBS\",\n      \"DNA Methylation\",\n      \"Epigenetics\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"bisulfite sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 55,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Raw bisulfite sequencing data (FASTQ format) used for DNA methylation analysis in the patient-derived cutaneous neurofibroma organoid model.\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data (FASTQ) from Cutaneous Neurofibroma Organoid Model\",\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"FASTQ\",\n      \"Raw Data\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 57,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) generated from the patient-derived cutaneous neurofibroma organoid model for gene expression analysis.\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data (FASTQ) from Cutaneous Neurofibroma Organoid Model (NF-OSI To Process)\",\n    \"creator\": [\n      \"Alice Soragni\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"FASTQ\",\n      \"Raw Data\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\",\n      \"NF-OSI\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 57,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from the cNF organoid model, designated for processing by NF-OSI (Neurofibromatosis Open Science Initiative).\",\n    \"contributor\": [\n      \"Alice Soragni\"\n    ]\n  },\n  {\n    \"title\": \"RNA Sequencing Data (FASTQ, Salmon) Failing QC from Cutaneous Neurofibroma Organoid Model\",\n    \"creator\": [\n      \"Alice Soragni\",\n      \"Sara Gosline\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"Gene Expression\",\n      \"FASTQ\",\n      \"Salmon\",\n      \"QC Fail\",\n      \"Cutaneous Neurofibroma\",\n      \"Organoid\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374354\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 2,\n    \"specimenCount\": 6,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"RNA sequencing data (FASTQ and Salmon quantification files) from the cNF organoid model that did not pass quality control checks.\",\n    \"contributor\": [\n      \"Alice Soragni\",\n      \"Sara Gosline\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7117,
    "candidatesTokenCount": 2618,
    "totalTokenCount": 9735,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7117
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374354"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Schwannomatosis Open Research Collaborative (SORC) - Viral Counts (CTAT-VIF)\",\n    \"alternateName\": \"SORC Viral Counts\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"contributor\": [\n      \"Schwannomatosis Open Research Collaborative\",\n      \"Sage Bionetworks\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Requires Synapse account, completion of Synapse user certification quiz, completed user profile (first name, last name, affiliation, ORCID), request access to specific files, and acceptance of Terms and Conditions of Use for Synodos Schwannomatosis Data.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"SWN\",\n      \"Virus Detection\",\n      \"Viral Counts\",\n      \"CTAT-VIF\",\n      \"RNA sequencing\",\n      \"Genomics\",\n      \"Synodos for Schwannomatosis\",\n      \"syn9727752\",\n      \"SORC\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"studyId\": \"syn28545963\",\n    \"diseaseFocus\": [\n      \"SMARCB1-related schwannomatosis\",\n      \"LZTR1-related schwannomatosis\",\n      \"22q-related schwannomatosis\",\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\",\n      \"NF2-related schwannomatosis\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Viral read counts derived from RNA-Seq data from the Synodos for Schwannomatosis initiative (syn9727752), reprocessed by the Schwannomatosis Open Research Collaborative (SORC) using the CTAT-VIF pipeline.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Virus diseases\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis Open Research Collaborative (SORC) - Whole Exome Sequencing (WES)\",\n    \"alternateName\": \"SORC WES Data\",\n    \"creator\": [\n      \"Schwannomatosis Open Research Collaborative\"\n    ],\n    \"contributor\": [\n      \"Schwannomatosis Open Research Collaborative\",\n      \"Sage Bionetworks\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Requires Synapse account, completion of Synapse user certification quiz, completed user profile (first name, last name, affiliation, ORCID), request access to specific files, and acceptance of Terms and Conditions of Use for Synodos Schwannomatosis Data.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"SWN\",\n      \"Whole Exome Sequencing\",\n      \"WES\",\n      \"Genomics\",\n      \"Variant Calling\",\n      \"Aligned Reads\",\n      \"Synodos for Schwannomatosis\",\n      \"syn9727752\",\n      \"nf-core\",\n      \"SORC\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\",\n      \"genomicVariants\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"studyId\": \"syn28545963\",\n    \"diseaseFocus\": [\n      \"SMARCB1-related schwannomatosis\",\n      \"LZTR1-related schwannomatosis\",\n      \"22q-related schwannomatosis\",\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\",\n      \"NF2-related schwannomatosis\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Whole Exome Sequencing (WES) data from the Synodos for Schwannomatosis initiative (syn9727752), reprocessed by the Schwannomatosis Open Research Collaborative (SORC) using nf-core pipelines. Contains aligned reads and variant call files.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Exome\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 427,
            "endIndex": 554,
            "uri": "https://forestnight.net/?_=%2Fposts%2Fiqvia_secure-research-environments-for-genomic-activity-7178465796824707072-NPOC%23KJWqMdlUlBn8PPpbXBTujI7xcY8uGFCs",
            "license": ""
          },
          {
            "startIndex": 2295,
            "endIndex": 2435,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          },
          {
            "startIndex": 5208,
            "endIndex": 5348,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          },
          {
            "startIndex": 7413,
            "endIndex": 7553,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          },
          {
            "startIndex": 13041,
            "endIndex": 13205,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          },
          {
            "startIndex": 14927,
            "endIndex": 15091,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6417,
    "candidatesTokenCount": 1121,
    "totalTokenCount": 7538,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6417
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn28545963"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Open Access\",\n    \"contributor\": [\n      \"Nancy Ratner, Ph.D.\",\n      \"Kwangmn Choi\"\n    ],\n    \"creator\": [\n      \"Nancy Ratner, Ph.D.\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Gene expression data (RNA-seq) from mouse models of Neurofibromatosis Type 1 (NF1) with plexiform neurofibromas. Includes differential expression analysis comparing different growth rates and drug responses, aiming to identify biomarkers for NF growth and therapy resistance.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 2,\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Plexiform Neurofibroma\",\n      \"Mouse Model\",\n      \"Gene Expression\",\n      \"RNA-seq\",\n      \"Drug Resistance\",\n      \"Biomarkers\",\n      \"Differential Gene Expression\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 2,\n    \"studyId\": \"syn4939892\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Gene expression\",\n      \"Mice as laboratory animals\",\n      \"Drug resistance\"\n    ],\n    \"title\": \"Gene Expression for Identification of Neurofibroma Growth and Drug Resistance Pathways\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5655,
    "candidatesTokenCount": 458,
    "totalTokenCount": 6113,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5655
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939892"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"ADVL1521 Omic Data Repository\",\n    \"creator\": [\n      \"Kevin Shannon\",\n      \"Mignon Loh\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"JMML\",\n      \"Juvenile Myelomonocytic Leukemia\",\n      \"single-cell RNA sequencing\",\n      \"scRNA-seq\",\n      \"gene expression\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Trametinib\",\n      \"MEK inhibitor\",\n      \"clinical trial\",\n      \"ADVL1521\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn51133946\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\",\n      \"Juvenile Myelomonocytic Leukemia (JMML)\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Single-cell RNA sequencing FASTQ files from 7 individuals (14 specimens) with Juvenile Myelomonocytic Leukemia (JMML) participating in the ADVL1521 clinical trial (DHART SPORE Project 3). This trial investigates the MEK inhibitor Trametinib. JMML is often associated with Neurofibromatosis type 1.\",\n    \"measurementTechnique\": [\n      \"single-cell RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 7,\n    \"specimenCount\": 14,\n    \"manifestation\": [\n      \"Juvenile Myelomonocytic Leukemia (JMML)\"\n    ],\n    \"contributor\": [\n      \"University of California, San Francisco\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"alternateName\": \"JMML scRNA-seq Data (ADVL1521 Trial)\",\n    \"subject\": [\n      \"Juvenile Myelomonocytic Leukemia\",\n      \"Neurofibromatosis Type 1\",\n      \"Single-Cell Analysis\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Clinical Trials as Topic\",\n      \"Trametinib\",\n      \"MEK kinase inhibitors\",\n      \"Hematopoietic Stem Cells\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 206,
            "endIndex": 341,
            "uri": "https://www.synapse.org/Synapse:syn51133946/challenge/",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5391,
    "candidatesTokenCount": 554,
    "totalTokenCount": 5945,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5391
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn51133946"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq\",\n    \"creator\": [\n      \"Edu Serra\"\n    ],\n    \"contributor\": [\n      \"NF Service\",\n      \"Edu Serra\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"quantification\",\n      \"iPS cells\",\n      \"PNF\",\n      \"Neurofibromatosis type 1\",\n      \"transcriptome\",\n      \"induced pluripotent stem cells\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"description\": \"Gene expression quantification data (Salmon format) derived from RNA-seq experiments on induced pluripotent stem cells (iPSCs) generated from Plexiform Neurofibroma (PNF) tissue.\",\n    \"alternateName\": \"PNF iPSC RNA-seq Quantification\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Methylation Array Data\",\n    \"creator\": [\n      \"Edu Serra\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Kaitlin Throgmorton\",\n      \"Edu Serra\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Methylation\",\n      \"DNA methylation\",\n      \"epigenetics\",\n      \"array\",\n      \"iPS cells\",\n      \"PNF\",\n      \"Neurofibromatosis type 1\",\n      \"chromatin activity\",\n      \"induced pluripotent stem cells\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Raw methylation data (IDAT files) from methylation arrays used to characterize induced pluripotent stem cells (iPSCs) derived from Plexiform Neurofibroma (PNF) tissue.\",\n    \"alternateName\": \"PNF iPSC Methylation Array Data\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data for NF-OSI Processing\",\n    \"creator\": [\n      \"Edu Serra\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Edu Serra\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"raw data\",\n      \"FASTQ\",\n      \"gene expression\",\n      \"iPS cells\",\n      \"PNF\",\n      \"Neurofibromatosis type 1\",\n      \"transcriptome\",\n      \"induced pluripotent stem cells\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from induced pluripotent stem cells (iPSCs) derived from Plexiform Neurofibroma (PNF) tissue, pending processing by NF-OSI.\",\n    \"alternateName\": \"PNF iPSC Raw RNA-seq Data\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA Sequencing Data\",\n    \"creator\": [\n      \"Edu Serra\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Christina Parry\",\n      \"Edu Serra\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"raw data\",\n      \"FASTQ\",\n      \"gene expression\",\n      \"iPS cells\",\n      \"PNF\",\n      \"Neurofibromatosis type 1\",\n      \"transcriptome\",\n      \"induced pluripotent stem cells\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 4,\n    \"specimenCount\": 27,\n    \"description\": \"Raw RNA sequencing data (FASTQ format) generated from induced pluripotent stem cells (iPSCs) derived from Plexiform Neurofibroma (PNF) tissue as part of the study on PNF cell of origin and malignant progression.\",\n    \"alternateName\": \"PNF iPSC RNA-seq FASTQ Data\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"SNP Array Genotyping Data\",\n    \"creator\": [\n      \"Edu Serra\"\n    ],\n    \"contributor\": [\n      \"Bernat Gel Moreno\",\n      \"Kaitlin Throgmorton\",\n      \"Edu Serra\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"SNP array\",\n      \"genotyping\",\n      \"genomic variants\",\n      \"iPS cells\",\n      \"PNF\",\n      \"Neurofibromatosis type 1\",\n      \"induced pluripotent stem cells\",\n      \"plexiform neurofibroma\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn4939918\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"measurementTechnique\": [\n      \"SNP array\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"description\": \"Genotyping data (TXT format) from SNP arrays used to characterize induced pluripotent stem cells (iPSCs) derived from Plexiform Neurofibroma (PNF) tissue.\",\n    \"alternateName\": \"PNF iPSC SNP Array Data\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 771,
            "endIndex": 952,
            "uri": "https://www.synapse.org/#!Synapse:syn4939918",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6219,
    "candidatesTokenCount": 1863,
    "totalTokenCount": 8082,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6219
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939918"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Compound Annotations from Evotec Drug Target Research\",\n    \"creator\": [\n      \"Tim James\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"compound\",\n      \"structure\",\n      \"annotation\",\n      \"drug discovery\",\n      \"Evotec\",\n      \"chemical properties\",\n      \"PubChem\",\n      \"ChEMBL\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn7239560\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Evotec\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Compound annotations and structural data from Evotec drug target research. Includes supplier structures, calculated properties, PubChem inactivity pairs, and ChEMBL matches.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Drugs--Structure\",\n      \"Drug targeting\",\n      \"Chemical structure\",\n      \"Molecular structure\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 4934,
    "candidatesTokenCount": 314,
    "totalTokenCount": 5248,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 4934
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn7239560"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"NTAP pNF Cell Line 10x10 Combination Drug Screen\",\n    \"contributor\": [\n      \"Marc Ferrer (NCATS)\"\n    ],\n    \"creator\": [\n      \"Marc Ferrer (NCATS)\"\n    ],\n    \"dataType\": [\n      \"drugCombinationScreen\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Results from 10x10 combination drug screens testing prioritized compounds on human NF1-/- primary Schwann cells derived from plexiform neurofibromas.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 4,\n    \"keywords\": [\n      \"drug screen\",\n      \"cell culture\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"combination therapy\",\n      \"NTAP\",\n      \"NCATS\",\n      \"10x10 screen\",\n      \"cell viability\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 4,\n    \"studyId\": \"syn4939906\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Drug Combinations\",\n      \"Cell Line\",\n      \"Schwann Cells\",\n      \"Antineoplastic Agents\"\n    ],\n    \"title\": \"10x10 Combination Screens of pNF Cell Lines\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"NTAP pNF Cell Line 6x6 Combination Drug Screen\",\n    \"contributor\": [\n      \"Marc Ferrer (NCATS)\"\n    ],\n    \"creator\": [\n      \"Marc Ferrer (NCATS)\"\n    ],\n    \"dataType\": [\n      \"drugCombinationScreen\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Results from 6x6 combination drug screens testing top hit compounds on human NF1-/- primary Schwann cells derived from plexiform neurofibromas.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 6,\n    \"keywords\": [\n      \"drug screen\",\n      \"cell culture\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"combination therapy\",\n      \"NTAP\",\n      \"NCATS\",\n      \"6x6 screen\",\n      \"cell viability\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 6,\n    \"studyId\": \"syn4939906\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Drug Combinations\",\n      \"Cell Line\",\n      \"Schwann Cells\",\n      \"Antineoplastic Agents\"\n    ],\n    \"title\": \"6x6 Combination Screens of pNF Cell Lines\"\n  },\n  {\n    \"accessType\": \"Open Access\",\n    \"alternateName\": \"NTAP pNF Cell Line Single Agent Drug Screen\",\n    \"contributor\": [\n      \"Marc Ferrer (NCATS)\"\n    ],\n    \"creator\": [\n      \"Marc Ferrer (NCATS)\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Results from single agent screens of the MIPE 4.0 small molecule library against multiple human and mouse NF1-related cell lines.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"individualCount\": 11,\n    \"keywords\": [\n      \"drug screen\",\n      \"cell culture\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"single agent\",\n      \"NTAP\",\n      \"NCATS\",\n      \"MIPE library\",\n      \"cell viability\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 11,\n    \"studyId\": \"syn4939906\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Drug Screening Assays, Antitumor\",\n      \"Cell Line\",\n      \"Schwann Cells\",\n      \"Antineoplastic Agents\",\n      \"Small Molecule Libraries\"\n    ],\n    \"title\": \"Single Agent Screens of pNF Cell Lines\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6017,
    "candidatesTokenCount": 1253,
    "totalTokenCount": 7270,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6017
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939906"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Colony forming assays\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Colony Forming Assay\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Cell Proliferation\",\n      \"Drug Combination\",\n      \"Statin\",\n      \"Farnesyltransferase Inhibitor\"\n    ],\n    \"dataType\": [\n      \"cell proliferation\"\n    ],\n    \"studyId\": \"syn53185180\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\",\n      \"Other\"\n    ],\n    \"description\": \"Data from colony forming assays evaluating the effect of combinational treatment with statin and farnesyltransferase inhibitor on NF1 Malignant Peripheral Nerve Sheath Tumor cell growth.\",\n    \"alternateName\": \"Colony Formation Data\",\n    \"contributor\": [\n      \"Raymond Mattingly\",\n      \"Wayne State University\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"cell proliferation\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Rattus norvegicus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell culture\",\n      \"Drug therapy--Combination\",\n      \"Antineoplastic agents\",\n      \"Ras proteins\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5036,
    "candidatesTokenCount": 436,
    "totalTokenCount": 5472,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5036
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn53185180"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Whole Body MRI of NF Patients\",\n    \"creator\": [\n      \"Dr. Wenli Cai\",\n      \"Dr. Gordon Harris\"\n    ],\n    \"contributor\": [\n      \"Robert Allaway\",\n      \"Jineta Banerjee\",\n      \"Massachusetts General Hospital (MGH)\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Requires registration and data access request approval via Synapse.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF\",\n      \"NF1\",\n      \"NF2\",\n      \"Schwannomatosis\",\n      \"Whole Body MRI\",\n      \"MRI\",\n      \"Imaging\",\n      \"Magnetic Resonance Imaging\",\n      \"STIR\",\n      \"T1\",\n      \"Massachusetts General Hospital\",\n      \"MGH\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"measurementTechnique\": [\n      \"conventional MRI\"\n    ],\n    \"studyId\": \"syn20608511\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 9,\n    \"specimenCount\": 9,\n    \"description\": \"Whole body Magnetic Resonance Imaging (WB MRI) data (T1 and STIR sequences) from 9 individuals diagnosed with Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), or Schwannomatosis. Collected at Massachusetts General Hospital (MGH) for research on tumor diagnosis and disease progression.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Ethics Approval Required\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"subject\": [\n      \"Neurofibromatoses\",\n      \"Magnetic resonance imaging\",\n      \"Diagnostic imaging\"\n    ],\n    \"alternateName\": \"MGH NF Whole Body MRI\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5274,
    "candidatesTokenCount": 474,
    "totalTokenCount": 5748,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5274
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn20608511"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Histopathology - Human PN , ANNUBP and MPNST Specimens\",\n    \"creator\": [\n      \"D. Wade Clapp\",\n      \"Jaishri Blakeley\",\n      \"Brigitte Widemann\",\n      \"Lu Le\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Histopathology\",\n      \"Microscopy\",\n      \"Image\",\n      \"Neurofibromatosis Type 1\",\n      \"Plexiform Neurofibroma\",\n      \"MPNST\",\n      \"ANNUBP\",\n      \"Human\",\n      \"DHART SPORE\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn51133914\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"Indiana University\",\n      \"Johns Hopkins University\",\n      \"National Institutes of Health\",\n      \"University of Texas Southwestern Medical Center\",\n      \"Steven Rhodes\",\n      \"Andrew Horvai\",\n      \"Elliot Stieglitz\"\n    ],\n    \"description\": \"Histopathology images (brightfield microscopy) from human plexiform neurofibroma (PN), atypical neurofibroma neurofibromatosis-associated neoplasm (ANNUBP), and malignant peripheral nerve sheath tumor (MPNST) specimens from individuals with Neurofibromatosis type 1.\",\n    \"individualCount\": 30,\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Aneurysmal Bone Cyst (ANNUBP)\",\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"brightfield microscopy\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 61,\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Pathology, Surgical\",\n      \"Microscopy\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Van Andel - Kinome\",\n    \"creator\": [\n      \"D. Wade Clapp\",\n      \"Jaishri Blakeley\",\n      \"Brigitte Widemann\",\n      \"Lu Le\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Kinomics\",\n      \"Kinome\",\n      \"Profiling\",\n      \"Neurofibromatosis Type 1\",\n      \"Human\",\n      \"DHART SPORE\",\n      \"Van Andel Institute\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn51133914\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NIH-NCI\"\n    ],\n    \"contributor\": [\n      \"Indiana University\",\n      \"Johns Hopkins University\",\n      \"National Institutes of Health\",\n      \"University of Texas Southwestern Medical Center\",\n      \"Steven Angus\",\n      \"Sara Gosline\"\n    ],\n    \"description\": \"Kinome profiling data from human specimens related to Neurofibromatosis type 1, generated by the Van Andel Institute as part of the DHART SPORE project.\",\n    \"individualCount\": 16,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Protein Kinases\",\n      \"Proteomics\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 1379,
            "endIndex": 1502,
            "uri": "https://www.synapse.org/Synapse:syn51133924/datasets/",
            "license": ""
          },
          {
            "startIndex": 4937,
            "endIndex": 5060,
            "uri": "https://www.synapse.org/Synapse:syn51133924/datasets/",
            "license": ""
          },
          {
            "startIndex": 8556,
            "endIndex": 8703,
            "uri": "https://www.synapse.org/Synapse:syn51133924/datasets/",
            "license": ""
          },
          {
            "startIndex": 10220,
            "endIndex": 10367,
            "uri": "https://www.synapse.org/Synapse:syn51133924/datasets/",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5558,
    "candidatesTokenCount": 911,
    "totalTokenCount": 6469,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5558
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn51133914"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"P2RY14 and NF1 Western Blot Source Data\",\n    \"creator\": [\n      \"Jennifer Patritti Cram\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"P2RY14\",\n      \"purinergic signaling\",\n      \"Western blot\",\n      \"ERK\",\n      \"AKT\",\n      \"mouse model\",\n      \"human\",\n      \"source data\",\n      \"neurofibroma\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn22268639\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Source data files (PDFs) for Western blots presented in figures investigating the role of P2RY14 purinergic signaling in Neurofibromatosis Type 1 (NF1). Includes analysis of total ERK, pAKT, and P2RY14 expression in human and humanized mouse model samples.\",\n    \"contributor\": [\n      \"Jennifer Patritti Cram\",\n      \"Cincinnati Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus (humanized)\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis\",\n      \"Western blotting\",\n      \"Signal transduction\",\n      \"Mus\",\n      \"Homo sapiens\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6063,
    "candidatesTokenCount": 455,
    "totalTokenCount": 6518,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6063
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn22268639"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"EGA Raw Data (requires approval on EGA)\",\n    \"conditionsOfAccess\": \"Data is stored in EGA (EGAD00001008608) and requires application and approval via EGA for access. Data is not available directly via Synapse.\",\n    \"contributor\": [\n      \"NFRI - Genomics of MPNST (GeM) Consortium\",\n      \"Boston Children's Hospital\"\n    ],\n    \"creator\": [\n      \"David Miller\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Raw FASTQ files from whole transcriptomic sequencing of Malignant Peripheral Nerve Sheath Tumor (MPNST) samples, primarily from individuals with Neurofibromatosis Type 1. Data requires approval and access via EGA (EGAD00001008608).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"individualCount\": 79,\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Transcriptomics\",\n      \"RNA-Seq\",\n      \"Raw Data\",\n      \"FASTQ\",\n      \"EGA\",\n      \"Genomics\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 139,\n    \"studyId\": \"syn32128792\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Transcriptomics\",\n      \"RNA Sequencing\",\n      \"Genomics\"\n    ],\n    \"title\": \"Genomic landscape of MPNST (GeM Consortium) - Raw RNA-Seq Data (FASTQ)\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"EGAD00001008608 RNA-Seq Processed Data - quant.genes.sf (requires approval on EGA)\",\n    \"conditionsOfAccess\": \"Data is stored in EGA (EGAD00001008608) and requires application and approval via EGA for access. Data is not available directly via Synapse.\",\n    \"contributor\": [\n      \"NFRI - Genomics of MPNST (GeM) Consortium\",\n      \"Boston Children's Hospital\"\n    ],\n    \"creator\": [\n      \"David Miller\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed gene-level quantification data (Salmon format) from RNA sequencing of Malignant Peripheral Nerve Sheath Tumor (MPNST) samples, primarily from individuals with NF1. Data requires approval and access via EGA (EGAD00001008608).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"individualCount\": 79,\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Transcriptomics\",\n      \"RNA-Seq\",\n      \"Processed Data\",\n      \"Gene Expression\",\n      \"Quantification\",\n      \"EGA\",\n      \"Genomics\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 139,\n    \"studyId\": \"syn32128792\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Transcriptomics\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Genomics\"\n    ],\n    \"title\": \"Genomic landscape of MPNST (GeM Consortium) - Processed RNA-Seq Gene Quantification (Salmon)\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"EGAD00001008608 RNA-Seq Processed Data - quant.sf (requires approval on EGA)\",\n    \"conditionsOfAccess\": \"Data is stored in EGA (EGAD00001008608) and requires application and approval via EGA for access. Data is not available directly via Synapse.\",\n    \"contributor\": [\n      \"NFRI - Genomics of MPNST (GeM) Consortium\",\n      \"Boston Children's Hospital\"\n    ],\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed transcript-level quantification data (Salmon format) from RNA sequencing of Malignant Peripheral Nerve Sheath Tumor (MPNST) samples, primarily from individuals with NF1. Data requires approval and access via EGA (EGAD00001008608).\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"individualCount\": 79,\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"NF1\",\n      \"Neurofibromatosis type 1\",\n      \"Transcriptomics\",\n      \"RNA-Seq\",\n      \"Processed Data\",\n      \"Transcript Expression\",\n      \"Quantification\",\n      \"EGA\",\n      \"Genomics\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 139,\n    \"studyId\": \"syn32128792\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Malignant Peripheral Nerve Sheath Neoplasms\",\n      \"Transcriptomics\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Genomics\"\n    ],\n    \"title\": \"Genomic landscape of MPNST (GeM Consortium) - Processed RNA-Seq Transcript Quantification (Salmon)\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5458,
    "candidatesTokenCount": 1657,
    "totalTokenCount": 7115,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5458
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn32128792"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"LZTR1 Substrate Identification Proteomics Data\",\n    \"creator\": [\n      \"Aram Ko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Accessing the data from this study requires a Synapse account.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"proteomics\",\n      \"mass spectrometry\",\n      \"TMT\",\n      \"LZTR1\",\n      \"CUL3\",\n      \"ubiquitin ligase\",\n      \"schwannomatosis\",\n      \"Glioblastoma\",\n      \"EGFR\",\n      \"AXL\",\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn22268689\",\n    \"diseaseFocus\": [\n      \"LZTR1-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Mohammad Hasanain\",\n      \"Young Taek Oh\",\n      \"Fabio D'Angelo\",\n      \"Deborah Sommer\",\n      \"Blerina Frangaj\",\n      \"Steven Tran\",\n      \"Franck Bielle\",\n      \"Bianca Pollo\",\n      \"Rossella Paterra\",\n      \"Karim Mokhtari\",\n      \"Rajiv K. Soni\",\n      \"Matthieu Peyre\",\n      \"Marica Eoli\",\n      \"Laura Papi\",\n      \"Michel Kalamarides\",\n      \"Marc Sanson\",\n      \"Antonio Iavarone\",\n      \"Anna Lasorella\",\n      \"James Moon\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Proteomics data, including mass spectrometry and TMT quantitation, characterizing LZTR1 substrates and functions, particularly in the context of Glioblastoma. Data derived from Homo sapiens and Mus musculus samples.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Glioblastoma\"\n    ],\n    \"measurementTechnique\": [\n      \"mass spectrometry\",\n      \"TMT quantitation\"\n    ],\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 1,\n    \"subject\": [\n      \"Proteomics\",\n      \"Mass spectrometry\",\n      \"Ubiquitin ligases\",\n      \"LZTR1 protein, human\",\n      \"LZTR1 protein, mouse\",\n      \"Schwannomatosis\",\n      \"Glioblastoma\",\n      \"Neoplasm Proteins\",\n      \"Signal transduction\"\n    ]\n  },\n  {\n    \"title\": \"LZTR1 In Vitro Cell Viability Assay Data\",\n    \"creator\": [\n      \"Aram Ko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Accessing the data from this study requires a Synapse account.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"in vitro\",\n      \"cell viability\",\n      \"drug screen\",\n      \"LZTR1\",\n      \"schwannomatosis\",\n      \"Mus musculus\",\n      \"assay\"\n    ],\n    \"dataType\": [\n      \"drugCombinationScreen\"\n    ],\n    \"studyId\": \"syn22268689\",\n    \"diseaseFocus\": [\n      \"LZTR1-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"contributor\": [\n      \"Mohammad Hasanain\",\n      \"Young Taek Oh\",\n      \"Fabio D'Angelo\",\n      \"Deborah Sommer\",\n      \"Blerina Frangaj\",\n      \"Steven Tran\",\n      \"Franck Bielle\",\n      \"Bianca Pollo\",\n      \"Rossella Paterra\",\n      \"Karim Mokhtari\",\n      \"Rajiv K. Soni\",\n      \"Matthieu Peyre\",\n      \"Marica Eoli\",\n      \"Laura Papi\",\n      \"Michel Kalamarides\",\n      \"Marc Sanson\",\n      \"Antonio Iavarone\",\n      \"Anna Lasorella\",\n      \"James Moon\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"In vitro cell viability assay data investigating cellular responses, likely related to LZTR1 function or pathway modulation. Data derived from Mus musculus samples.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Cell viability\",\n      \"Drug screening assays\",\n      \"LZTR1 protein, mouse\",\n      \"Schwannomatosis\",\n      \"Mus musculus\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 1009,
            "endIndex": 1199,
            "uri": "https://pitiesalpetriere.aphp.fr/centre-de-ressources-biologiques/",
            "license": ""
          },
          {
            "startIndex": 1072,
            "endIndex": 1364,
            "uri": "https://www.synapse.org/Synapse:syn22268689",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5856,
    "candidatesTokenCount": 1167,
    "totalTokenCount": 7023,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5856
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn22268689"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"12 month deliverables - NF1 iPSC Sensory Neuron-Schwann Cell Co-culture\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Induced Pluripotent Stem Cells\",\n      \"iPSC\",\n      \"Sensory Neurons\",\n      \"Schwann Cells\",\n      \"Co-culture\",\n      \"Immunofluorescence\",\n      \"Gene Expression\",\n      \"Progress Report\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"David H. Gutmann\",\n      \"Corina Anastasaki\",\n      \"Jason B. Papke\",\n      \"Morgan E. Freret\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\",\n      \"quantitative PCR\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Progress report data from month 12, including immunofluorescence images and gene expression data from human iPSC-derived sensory neuron and Schwann cell co-cultures, investigating NF1 gene mutations.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"18 month deliverables - NF1 iPSC Sensory Neuron-Schwann Cell Co-culture (Jan 2020)\",\n    \"creator\": [\n      \"Corina Anastasaki\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Induced Pluripotent Stem Cells\",\n      \"iPSC\",\n      \"Sensory Neurons\",\n      \"Schwann Cells\",\n      \"Co-culture\",\n      \"Immunocytochemistry\",\n      \"Gene Expression\",\n      \"Progress Report\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"David H. Gutmann\",\n      \"Corina Anastasaki\",\n      \"Jason B. Papke\",\n      \"Morgan E. Freret\",\n      \"Christina Parry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": [\n      \"immunocytochemistry\",\n      \"quantitative PCR\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Progress report data from month 18 (Jan 2020), including immunocytochemistry images and gene expression data from human iPSC-derived sensory neuron and Schwann cell co-cultures related to NF1.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"30 month deliverables - NF1 iPSC Sensory Neuron-Schwann Cell Co-culture and MEA (Dec 2020)\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Induced Pluripotent Stem Cells\",\n      \"iPSC\",\n      \"Sensory Neurons\",\n      \"Schwann Cells\",\n      \"Co-culture\",\n      \"Electrophysiology\",\n      \"Cell Proliferation\",\n      \"Western Blot\",\n      \"Immunocytochemistry\",\n      \"Immunohistochemistry\",\n      \"MEA\",\n      \"Progress Report\"\n    ],\n    \"dataType\": [\n      \"electrophysiology\",\n      \"image\",\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"David H. Gutmann\",\n      \"Corina Anastasaki\",\n      \"Jason B. Papke\",\n      \"Morgan E. Freret\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"measurementTechnique\": [\n      \"local field potential recording\",\n      \"array\",\n      \"cell proliferation\",\n      \"cell count\",\n      \"western blot\",\n      \"immunocytochemistry\",\n      \"immunohistochemistry\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Progress report data from month 30 (Dec 2020), including electrophysiology (MEA), cell proliferation/count, western blot, and imaging data from human iPSC and mouse models related to NF1 sensory neuron and Schwann cell interactions.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"6 month deliverables - NF1 iPSC Sensory Neuron-Schwann Cell Co-culture\",\n    \"creator\": [\n      \"Corina Anastasaki\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Induced Pluripotent Stem Cells\",\n      \"iPSC\",\n      \"Sensory Neurons\",\n      \"Schwann Cells\",\n      \"Co-culture\",\n      \"Immunocytochemistry\",\n      \"Western Blot\",\n      \"Quantitative PCR\",\n      \"Progress Report\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374345\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"David H. Gutmann\",\n      \"Corina Anastasaki\",\n      \"Jason B. Papke\",\n      \"Morgan E. Freret\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 2,\n    \"measurementTechnique\": [\n      \"immunocytochemistry\",\n      \"western blot\",\n      \"quantitative PCR\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"description\": \"Progress report data from month 6, including immunocytochemistry images, western blots, and qPCR data from human iPSC-derived sensory neuron and Schwann cell co-cultures investigating NF1. Contains data from 2 specimens.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 370,
            "endIndex": 534,
            "uri": "http://www.n-tap.org/nf1-and-cutaneous-neurofibroma/",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5961,
    "candidatesTokenCount": 1790,
    "totalTokenCount": 7751,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5961
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374345"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Deep Variant Tumor Calls\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"Variant Calling\",\n      \"Tumor\",\n      \"Genomics\",\n      \"DeepVariant\"\n    ],\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn53604698\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Somatic variant calls generated using the DeepVariant algorithm on tumor samples from the Synodos for Schwannomatosis project.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Mutation\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis Methylation Array Data\",\n    \"creator\": [\n      \"Sheila Mansouri\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"Methylation\",\n      \"Epigenomics\",\n      \"Array\",\n      \"IDAT\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn64954726\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"individualCount\": 45,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Raw methylation array intensity data (IDAT files) from schwannoma specimens collected for the Synodos for Schwannomatosis study. Data generated using methylation arrays.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"methylation array\"\n    ],\n    \"specimenCount\": 91,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Epigenomics\",\n      \"DNA Methylation\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq Raw Data (fastq)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"RNA-seq\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"fastq\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn64954727\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"individualCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ files) from schwannoma specimens collected for the Synodos for Schwannomatosis study.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 24,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Synodos Schwannomatosis Intermediate Processing Data (2020-05-13)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"Data Processing\",\n      \"Intermediate Files\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn30423895\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Intermediate data files generated during processing steps for the Synodos for Schwannomatosis project, snapshotted on 2020-05-13.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Bioinformatics\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq Merged Raw Data (fastq)\",\n    \"creator\": [\n      \"NF-OSI\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"RNA-seq\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"fastq\",\n      \"Merged\",\n      \"NF-OSI\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn43709762\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\",\n      \"Robert Allaway\"\n    ],\n    \"individualCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Merged raw RNA sequencing data (FASTQ files) from schwannoma specimens, processed by NF-OSI for the Synodos for Schwannomatosis study.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"series\": \"NF-OSI Processed Data\",\n    \"specimenCount\": 24,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq Unmerged Raw Data (fastq)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"RNA-seq\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"fastq\",\n      \"Unmerged\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn41825491\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"individualCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Original, unmerged raw RNA sequencing data (FASTQ files) from schwannoma specimens for the Synodos for Schwannomatosis study. Corresponds to the merged data in syn43709762.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 24,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis RNA-seq Quantification Data (Salmon sf)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"RNA-seq\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"Quantification\",\n      \"Salmon\",\n      \"sf\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn63540453\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"individualCount\": 14,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Gene and transcript quantification data (Salmon sf files) derived from RNA-seq of schwannoma specimens from the Synodos for Schwannomatosis study.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"specimenCount\": 22,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Transcriptomics\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Synodos Schwannomatosis Somatic Mutations (Strelka, VCF)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"Somatic Mutations\",\n      \"Genomics\",\n      \"Variant Calling\",\n      \"Strelka\",\n      \"VCF\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn53403828\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Somatic single nucleotide variants (SNVs) identified using Strelka in schwannoma samples compared to matched normal samples from the Synodos for Schwannomatosis project. Data provided in VCF format.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\",\n      \"whole genome sequencing\"\n    ],\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Mutation\",\n      \"Sequence Analysis, DNA\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis Somatic Variants from WES (Strelka, VCF)\",\n    \"creator\": [\n      \"Sasha Scott\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"Somatic Variants\",\n      \"Genomics\",\n      \"Variant Calling\",\n      \"Strelka\",\n      \"VCF\",\n      \"WES\",\n      \"Whole Exome Sequencing\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn64720237\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Somatic SNVs and INDELs identified using Strelka from whole exome sequencing (WES) of schwannoma samples and matched normal samples from the Synodos for Schwannomatosis project. Data in VCF format.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"specimenCount\": 40,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Mutation\",\n      \"Sequence Analysis, DNA\",\n      \"Exome\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis Whole Genome Sequencing Raw Data (fastq)\",\n    \"creator\": [\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"WGS\",\n      \"Whole Genome Sequencing\",\n      \"Genomics\",\n      \"fastq\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn64954728\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"individualCount\": 8,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Raw whole genome sequencing data (FASTQ files) from tumor and blood specimens collected for the Synodos for Schwannomatosis study.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"specimenCount\": 18,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Sequence Analysis, DNA\",\n      \"Whole Genome Sequencing\",\n      \"Schwannoma\"\n    ]\n  },\n  {\n    \"title\": \"Schwannomatosis Whole Exome Sequencing Raw Data (fastq)\",\n    \"creator\": [\n      \"Fulvio D'Angelo\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Schwannomatosis\",\n      \"WES\",\n      \"Whole Exome Sequencing\",\n      \"Genomics\",\n      \"fastq\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn9727752\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\",\n      \"Schwannomatosis-NEC\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"syn64954729\",\n    \"conditionsOfAccess\": \"User registration required.\",\n    \"contributor\": [\n      \"Scott Plotkin\",\n      \"James Gusella\",\n      \"Matthias Karajannis\",\n      \"Vijaya Ramesh\",\n      \"Marco Giovannini\",\n      \"Lan Kluwe\",\n      \"Gelareh Zadeh\",\n      \"Jean-Philippe Brosseau\"\n    ],\n    \"individualCount\": 38,\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"description\": \"Raw whole exome sequencing data (FASTQ files) from tumor and blood specimens collected for the Synodos for Schwannomatosis study.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"specimenCount\": 91,\n    \"subject\": [\n      \"Schwannomatosis\",\n      \"Genomics\",\n      \"Sequence Analysis, DNA\",\n      \"Exome\",\n      \"Schwannoma\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7406,
    "candidatesTokenCount": 5365,
    "totalTokenCount": 12771,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7406
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn9727752"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Screening of Plexiform Neurofibroma Models in 96-well Format\",\n    \"creator\": [\n      \"Raymond Mattingly\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"plexiform neurofibroma\",\n      \"Neurofibromatosis type 1\",\n      \"drug screen\",\n      \"cell viability\",\n      \"3D culture\",\n      \"2D culture\",\n      \"96-well format\",\n      \"secondary screen\",\n      \"confirmatory screen\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn4939916\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Drug screen data from 2D and 3D cultures of Neurofibromatosis type 1 plexiform neurofibroma models in 96-well format, using a cell viability assay. This work aimed to develop secondary screening methods and compare drug sensitivity between 2D and 3D models.\",\n    \"contributor\": [\n      \"Markiesha Baines\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis type 1\",\n      \"Plexiform neurofibroma\",\n      \"Drug screening\",\n      \"Cell culture techniques\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5479,
    "candidatesTokenCount": 441,
    "totalTokenCount": 5920,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5479
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939916"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"12 month deliverables\",\n    \"creator\": [\n      \"Lu Le\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"NTAP\",\n      \"immunofluorescence\",\n      \"image\",\n      \"deliverables\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Image data deliverables for month 12 of the Cutaneous Neurofibroma: Models, Biology and Translation project (syn11374333).\",\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"specimenCount\": 1,\n    \"contributor\": [\n      \"Lu Q. Le\",\n      \"University of Texas Southwestern Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Immunofluorescence\",\n      \"Microscopy, Fluorescence\"\n    ]\n  },\n  {\n    \"title\": \"18 month deliverables\",\n    \"creator\": [\n      \"Lu Le\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"NTAP\",\n      \"immunofluorescence\",\n      \"image\",\n      \"deliverables\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Image data deliverables for month 18 of the Cutaneous Neurofibroma: Models, Biology and Translation project (syn11374333).\",\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Lu Q. Le\",\n      \"University of Texas Southwestern Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Immunofluorescence\",\n      \"Microscopy, Fluorescence\"\n    ]\n  },\n  {\n    \"title\": \"24 month deliverables\",\n    \"creator\": [\n      \"Lu Le\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"NTAP\",\n      \"immunofluorescence\",\n      \"brightfield microscopy\",\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"immunocytochemistry\",\n      \"western blot\",\n      \"gene expression\",\n      \"image\",\n      \"deliverables\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Gene expression and image data deliverables for month 24 of the Cutaneous Neurofibroma: Models, Biology and Translation project (syn11374333).\",\n    \"measurementTechnique\": [\n      \"immunofluorescence\",\n      \"brightfield microscopy\",\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"immunocytochemistry\",\n      \"western blot\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Lu Q. Le\",\n      \"University of Texas Southwestern Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Gene Expression\",\n      \"Microscopy\",\n      \"Immunohistochemistry\",\n      \"Immunocytochemistry\",\n      \"Western Blotting\",\n      \"Real-Time Polymerase Chain Reaction\"\n    ]\n  },\n  {\n    \"title\": \"36 month deliverables\",\n    \"creator\": [\n      \"Renee McKay\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"NTAP\",\n      \"immunohistochemistry\",\n      \"reporter gene assay\",\n      \"brightfield microscopy\",\n      \"immunofluorescence\",\n      \"cell count\",\n      \"whole exome sequencing\",\n      \"gene expression\",\n      \"image\",\n      \"deliverables\",\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Gene expression and image data deliverables for month 36 of the Cutaneous Neurofibroma: Models, Biology and Translation project (syn11374333).\",\n    \"measurementTechnique\": [\n      \"immunohistochemistry\",\n      \"reporter gene assay\",\n      \"brightfield microscopy\",\n      \"immunofluorescence\",\n      \"cell count\",\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Lu Q. Le\",\n      \"University of Texas Southwestern Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Plexiform Neurofibroma\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Gene Expression\",\n      \"Microscopy\",\n      \"Immunohistochemistry\",\n      \"Immunofluorescence\",\n      \"Whole Exome Sequencing\",\n      \"Genes, Reporter\",\n      \"Cell Count\",\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ]\n  },\n  {\n    \"title\": \"6 month deliverables\",\n    \"creator\": [\n      \"Lu Le\",\n      \"Robert Allaway\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"NTAP\",\n      \"immunofluorescence\",\n      \"image\",\n      \"deliverables\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374333\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Image data deliverables for month 6 of the Cutaneous Neurofibroma: Models, Biology and Translation project (syn11374333).\",\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"specimenCount\": 1,\n    \"contributor\": [\n      \"Lu Q. Le\",\n      \"University of Texas Southwestern Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Neoplasms, Nerve Tissue\",\n      \"Immunofluorescence\",\n      \"Microscopy, Fluorescence\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6175,
    "candidatesTokenCount": 2227,
    "totalTokenCount": 8402,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6175
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374333"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"AAV Ascl1 v YapS5A EdU\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Mus musculus\",\n      \"mouse\",\n      \"AAV\",\n      \"Ascl1\",\n      \"YapS5A\",\n      \"EdU\",\n      \"immunofluorescence\",\n      \"raw counts\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Raw counts from immunofluorescence assays comparing AAV Ascl1 versus YapS5A EdU treatment effects in Mus musculus retina models, related to NF1 vision loss research.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Gene expression\",\n      \"Mus musculus\",\n      \"Immunofluorescence\"\n    ]\n  },\n  {\n    \"title\": \"AAV Ascl1 v YapS5A EdU image\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Mus musculus\",\n      \"mouse\",\n      \"AAV\",\n      \"Ascl1\",\n      \"YapS5A\",\n      \"EdU\",\n      \"immunofluorescence\",\n      \"image\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Immunofluorescence images comparing AAV Ascl1 versus YapS5A EdU treatment effects in Mus musculus retina models, related to NF1 vision loss research.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Gene expression\",\n      \"Mus musculus\",\n      \"Immunofluorescence\",\n      \"Microscopy\"\n    ]\n  },\n  {\n    \"title\": \"ATACseq Ascl1a lin28a OE v control uninj Muller glia\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Muller glia\",\n      \"ATAC-seq\",\n      \"Ascl1a\",\n      \"Lin28a\",\n      \"overexpression\",\n      \"chromatin accessibility\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\",\n      \"Christina Parry\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"ATAC-seq data investigating chromatin accessibility changes in uninjured zebrafish Muller glia following Ascl1a and Lin28a overexpression compared to control.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 4,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"ATAC-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"specimenCount\": 5,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Chromatin\",\n      \"M√ºller cells\",\n      \"ATAC-seq\"\n    ]\n  },\n  {\n    \"title\": \"ATACseq DAPT v DMSO\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Muller glia\",\n      \"ATAC-seq\",\n      \"DAPT\",\n      \"DMSO\",\n      \"chromatin accessibility\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"ATAC-seq data comparing chromatin accessibility in zebrafish Muller glia treated with DAPT versus DMSO control in uninjured retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"ATAC-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"specimenCount\": 1,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Chromatin\",\n      \"M√ºller cells\",\n      \"ATAC-seq\",\n      \"Drug effects\"\n    ]\n  },\n  {\n    \"title\": \"ATACseq inj v uninj\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Muller glia\",\n      \"ATAC-seq\",\n      \"injury\",\n      \"chromatin accessibility\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"ATAC-seq data comparing chromatin accessibility in zebrafish Muller glia between injured (4 dpi) and uninjured retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"ATAC-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"specimenCount\": 1,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Chromatin\",\n      \"M√ºller cells\",\n      \"ATAC-seq\",\n      \"Wound healing\"\n    ]\n  },\n  {\n    \"title\": \"Cxcl18b injury dependent gene expression\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Cxcl18b\",\n      \"gene expression\",\n      \"qPCR\",\n      \"injury\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Quantitative PCR data showing injury-dependent gene expression changes for Cxcl18b in zebrafish retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"quantitative PCR\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Chemokines\",\n      \"Wound healing\",\n      \"Quantitative real-time polymerase chain reaction\"\n    ]\n  },\n  {\n    \"title\": \"Cxcl18b knockdown EdU proliferation data\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Cxcl18b\",\n      \"knockdown\",\n      \"EdU\",\n      \"proliferation\",\n      \"immunoassay\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"EdU proliferation assay data investigating the effect of Cxcl18b knockdown on cell proliferation in zebrafish retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"EdU proliferation assay\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Chemokines\",\n      \"Cell proliferation\",\n      \"Gene knockdown techniques\"\n    ]\n  },\n  {\n    \"title\": \"Zebrafish Retina Regeneration Drug Screen\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"drug screen\",\n      \"small molecules\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Data from a drug screen testing small molecules for their effect on retina regeneration in zebrafish.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"small molecule library screen\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish\",\n      \"Drug screening\",\n      \"Small molecules\",\n      \"Pharmacology\"\n    ]\n  },\n  {\n    \"title\": \"Flt1 knockdown and mutant EdU injury data\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Flt1\",\n      \"knockdown\",\n      \"mutant\",\n      \"EdU\",\n      \"proliferation\",\n      \"injury\",\n      \"immunofluorescence\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Immunofluorescence and EdU proliferation data examining the effects of Flt1 knockdown and mutation on cell proliferation following injury in zebrafish retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\",\n      \"EdU proliferation assay\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Vascular endothelial growth factor receptors\",\n      \"Cell proliferation\",\n      \"Gene knockdown techniques\",\n      \"Mutation (Biology)\"\n    ]\n  },\n  {\n    \"title\": \"Images of NF1 knockdown effect in zebrafish retina\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"NF1\",\n      \"knockdown\",\n      \"immunofluorescence\",\n      \"image\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Immunofluorescence images showing the effects of NF1 knockdown in zebrafish retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"specimenCount\": 1,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Gene knockdown techniques\",\n      \"Immunofluorescence\",\n      \"Microscopy\"\n    ]\n  },\n  {\n    \"title\": \"Myc family gene expression and functional data\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Myc\",\n      \"gene expression\",\n      \"qPCR\",\n      \"immunofluorescence\",\n      \"EdU\",\n      \"TUNEL\",\n      \"proliferation\",\n      \"apoptosis\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"cellularPhysiology\",\n      \"image\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Data related to Myc family genes in zebrafish retina regeneration, including qPCR gene expression, immunofluorescence images, and EdU/TUNEL assays for proliferation and apoptosis.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"quantitative PCR\",\n      \"immunofluorescence\",\n      \"EdU proliferation assay\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Proto-Oncogene Proteins c-myc\",\n      \"Cell proliferation\",\n      \"Apoptosis\",\n      \"Quantitative real-time polymerase chain reaction\",\n      \"Immunofluorescence\"\n    ]\n  },\n  {\n    \"title\": \"NF1 and Ascl1a qPCR data after NF1 morpholino knockdown\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"NF1\",\n      \"Ascl1a\",\n      \"qPCR\",\n      \"morpholino\",\n      \"knockdown\",\n      \"gene expression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Quantitative PCR data measuring NF1 and Ascl1a gene expression levels following NF1 morpholino knockdown in zebrafish.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"quantitative PCR\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"specimenCount\": 1,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Gene knockdown techniques\",\n      \"Quantitative real-time polymerase chain reaction\"\n    ]\n  },\n  {\n    \"title\": \"RNAseq Ascl1a-Lin28a overexpression vs control in zebrafish retina\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"Ascl1a\",\n      \"Lin28a\",\n      \"overexpression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"RNA-seq data comparing gene expression profiles in zebrafish retinas with Ascl1a and Lin28a overexpression versus control conditions.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"specimenCount\": 1,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Transcriptomics\",\n      \"RNA-Seq\"\n    ]\n  },\n  {\n    \"title\": \"RNAseq DAPT vs DMSO treatment in zebrafish Muller glia\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Muller glia\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"DAPT\",\n      \"DMSO\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"RNA-seq data comparing gene expression profiles in zebrafish Muller glia treated with DAPT versus DMSO control.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"M√ºller cells\",\n      \"Transcriptomics\",\n      \"RNA-Seq\",\n      \"Drug effects\"\n    ]\n  },\n  {\n    \"title\": \"RNAseq injured vs uninjured zebrafish Muller glia\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Muller glia\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"injury\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"RNA-seq data comparing gene expression profiles in zebrafish Muller glia from injured versus uninjured retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"M√ºller cells\",\n      \"Transcriptomics\",\n      \"RNA-Seq\",\n      \"Wound healing\"\n    ]\n  },\n  {\n    \"title\": \"RNAseq injured vs uninjured zebrafish non-Muller glia retinal cells\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"retina\",\n      \"non-Muller glia\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"injury\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"RNA-seq data comparing gene expression profiles in zebrafish non-Muller glia retinal cells from injured versus uninjured retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Retina\",\n      \"Transcriptomics\",\n      \"RNA-Seq\",\n      \"Wound healing\"\n    ]\n  },\n  {\n    \"title\": \"Vegf signaling component gene expression\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"Vegf\",\n      \"gene expression\",\n      \"qPCR\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Quantitative PCR data measuring gene expression levels of Vegf signaling components in zebrafish retinas.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"quantitative PCR\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Vascular endothelial growth factors\",\n      \"Signal transduction\",\n      \"Quantitative real-time polymerase chain reaction\"\n    ]\n  },\n  {\n    \"title\": \"Single-cell RNAseq of zebrafish retina\",\n    \"creator\": [\n      \"Daniel Goldman\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"retina regeneration\",\n      \"retinal ganglion cell\",\n      \"vision loss\",\n      \"Danio rerio\",\n      \"zebrafish\",\n      \"retina\",\n      \"scRNA-seq\",\n      \"single-cell\",\n      \"gene expression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21650493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"GFF\"\n    ],\n    \"contributor\": [\n      \"Aresh Sahu\",\n      \"Jonathan Jui\",\n      \"Sulochan Devi\",\n      \"Muchu Zhou\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Single-cell RNA sequencing data profiling gene expression in zebrafish retinal cells.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Vision Loss\"\n    ],\n    \"measurementTechnique\": [\n      \"single-cell RNA-seq\"\n    ],\n    \"species\": [\n      \"Danio rerio\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Retina -- Regeneration\",\n      \"Zebrafish -- Genetics\",\n      \"Gene expression\",\n      \"Retina\",\n      \"Single-cell analysis\",\n      \"Transcriptomics\",\n      \"RNA-Seq\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 8150,
    "candidatesTokenCount": 8041,
    "totalTokenCount": 16191,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 8150
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn21650493"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Proteasome-targeting drugs tested on NF2-deficient meningioma models\",\n    \"creator\": [\n      \"Vijaya Ramesh\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF2\",\n      \"Meningioma\",\n      \"drug screen\",\n      \"proteasome inhibitor\",\n      \"cell viability\",\n      \"CRISPR\",\n      \"arachnoidal cells\",\n      \"Ben-Men-1\",\n      \"MN597\",\n      \"AC-CRISPR\",\n      \"Massachusetts General Hospital\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn27761862\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Meningioma Drug Screen\",\n    \"contributor\": [\n      \"Roberta Beauchamp\",\n      \"Anh Nguyet Vu\",\n      \"Lei Xu\",\n      \"Massachusetts General Hospital\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Drug screen data evaluating the efficacy of proteasome-targeting drugs on NF2-deficient human meningioma cell lines (Ben-Men-1, MN597) and CRISPR-Cas9 edited arachnoidal cells (AC-CRISPR). Includes cell viability assay results.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Meningioma\"\n    ],\n    \"measurementTechnique\": [\n      \"cell viability assay\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Meningioma\",\n      \"Neurofibromatosis 2\",\n      \"Drug screening\",\n      \"Cell lines\",\n      \"Antineoplastic agents\",\n      \"Proteasome inhibitors\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5335,
    "candidatesTokenCount": 505,
    "totalTokenCount": 5840,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5335
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn27761862"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Kallionpaa et al., Dermatology 2022 - Brightfield Microscopy Images\",\n    \"creator\": [\n      \"Juha Peltonen\",\n      \"Sirkku Peltonen\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"brightfield microscopy\",\n      \"image\",\n      \"tumor microenvironment\",\n      \"mast cells\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374341\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Roope Kallionp√§√§\",\n      \"University of Turku\"\n    ],\n    \"description\": \"Brightfield microscopy images of human cutaneous neurofibromas from Neurofibromatosis type 1 patients, focusing on mast cells (CD117 staining).\",\n    \"individualCount\": 61,\n    \"specimenCount\": 183,\n    \"measurementTechnique\": [\n      \"brightfield microscopy\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neoplasms\",\n      \"Mast Cells\",\n      \"Microscopy\"\n    ]\n  },\n  {\n    \"title\": \"Kallionpaa et al., T Cell Receptor Sequencing of Cutaneous Neurofibromas\",\n    \"creator\": [\n      \"Juha Peltonen\",\n      \"Sirkku Peltonen\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"T cell receptor sequencing\",\n      \"genomicFeatures\",\n      \"tumor microenvironment\",\n      \"T-cells\",\n      \"immunity\"\n    ],\n    \"dataType\": [\n      \"genomicFeatures\"\n    ],\n    \"studyId\": \"syn11374341\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Roope Kallionp√§√§\",\n      \"University of Turku\"\n    ],\n    \"description\": \"T cell receptor (TCR) repertoire sequencing data from human cutaneous neurofibromas (cNFs) in Neurofibromatosis type 1 patients, investigating immune cell populations.\",\n    \"measurementTechnique\": [\n      \"T cell receptor repertoire sequencing\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neoplasms\",\n      \"T-Lymphocytes\",\n      \"Receptors, Antigen, T-Cell\",\n      \"Sequence Analysis, DNA\",\n      \"Tumor Microenvironment\"\n    ]\n  },\n  {\n    \"title\": \"Kallionpaa et al., Mass Spectrometry of Human Cutaneous Neurofibromas and Overlying Skin\",\n    \"creator\": [\n      \"Juha Peltonen\",\n      \"Sirkku Peltonen\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"proteomics\",\n      \"mass spectrometry\",\n      \"LC-MS/MS\",\n      \"skin\",\n      \"tumor microenvironment\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn11374341\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"contributor\": [\n      \"Roope Kallionp√§√§\",\n      \"University of Turku\"\n    ],\n    \"description\": \"Proteomic analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS) on human cutaneous neurofibromas and overlying skin samples from Neurofibromatosis type 1 patients.\",\n    \"measurementTechnique\": [\n      \"liquid chromatography/tandem mass spectrometry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neoplasms\",\n      \"Proteomics\",\n      \"Tandem Mass Spectrometry\",\n      \"Skin\",\n      \"Tumor Microenvironment\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5515,
    "candidatesTokenCount": 1311,
    "totalTokenCount": 6826,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5515
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374341"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Chronic injuries experiment\",\n    \"creator\": [\n      \"Piotr Topilko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"chronic injury\",\n      \"immunofluorescence\",\n      \"imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Immunofluorescence imaging data from chronic injury experiments in a mouse model of cutaneous neurofibroma.\",\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"individualCount\": 27,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Development of cNFs\",\n    \"creator\": [\n      \"Piotr Topilko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"development\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data related to the study of the development of cutaneous neurofibromas (cNFs) in a mouse model.\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Grafts of tumor cells into sciatic nerve\",\n    \"creator\": [\n      \"Piotr Topilko\",\n      \"Christina Parry\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"tumor graft\",\n      \"sciatic nerve\",\n      \"in vivo tumor growth\",\n      \"imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Imaging data from experiments involving grafts of cutaneous neurofibroma tumor cells into the sciatic nerve of mice.\",\n    \"measurementTechnique\": [\n      \"in vivo tumor growth\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"individualCount\": 11,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\",\n      \"Christina Parry\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Mouse model cutaneous imaging of chronic injuries\",\n    \"creator\": [\n      \"Piotr Topilko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"chronic injury\",\n      \"imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Imaging data from chronic injury experiments in a mouse model relevant to cutaneous neurofibroma.\",\n    \"measurementTechnique\": [\n      \"immunofluorescence\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"individualCount\": 27,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"NFOSI-RNASeq-To-Process-2023-15-03\",\n    \"creator\": [\n      \"Piotr Topilko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"raw data\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ files) from mouse model experiments, intended for NF-OSI processing pipeline.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"RNAseq Bulk Sphere P0 vs P5\",\n    \"creator\": [\n      \"Piotr Topilko\",\n      \"Kaitlin Throgmorton\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"sphere culture\",\n      \"P0\",\n      \"P5\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Bulk RNA sequencing data comparing gene expression in sphere cultures at passage 0 (P0) and passage 5 (P5) from an NF1 mouse model.\",\n    \"measurementTechnique\": [\n      \"RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\",\n      \"Kaitlin Throgmorton\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Single cell transcriptomic analysis, for the identification of new markers of supepidermal glia\",\n    \"creator\": [\n      \"Piotr Topilko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"single-cell RNA-seq\",\n      \"gene expression\",\n      \"supepidermal glia\",\n      \"markers\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Single-cell RNA sequencing data (FASTQ files) aimed at identifying new markers of supepidermal glia in a mouse model relevant to NF1.\",\n    \"measurementTechnique\": [\n      \"single-cell RNA-seq\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Vascular detection with Itae\",\n    \"creator\": [\n      \"Piotr Topilko\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"mouse model\",\n      \"vascular detection\",\n      \"imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374337\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Imaging data related to vascular detection in a mouse model relevant to NF1 cutaneous neurofibromas. Processed with Itae (presumed software/person).\",\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"contributor\": [\n      \"Piotr Topilko\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6670,
    "candidatesTokenCount": 2487,
    "totalTokenCount": 9157,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6670
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11374337"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Copy Number Variation Data (CNVkit) for NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"Copy Number Variation\",\n      \"CNV\",\n      \"CNVkit\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Copy number variation profiles derived from whole genome sequencing of NF1-MPNST patient-derived xenograft (PDX) models, generated using the CNVkit pipeline. Part of a study developing preclinical models for precision oncology.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"NF Service\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 10,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Filtered Single-Cell RNA Sequencing Data for NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"Single Cell\",\n      \"scRNA-seq\",\n      \"Transcriptomics\",\n      \"Gene Expression\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Gene expression counts from single-cell RNA sequencing of NF1-MPNST patient-derived xenograft (PDX) models. Data is filtered and presented in matrix format. Part of a study developing preclinical models.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"measurementTechnique\": [\n      \"single-cell RNA-seq\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants (DeepVariant) from WGS of NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"Germline Variants\",\n      \"WGS\",\n      \"DeepVariant\",\n      \"VCF\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Germline single nucleotide variants (SNVs) and short insertions/deletions (indels) identified using the DeepVariant pipeline from whole genome sequencing (WGS) of NF1-MPNST patient-derived xenograft (PDX) models.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"NF Service\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants (FreeBayes) from WGS of NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"Germline Variants\",\n      \"WGS\",\n      \"FreeBayes\",\n      \"VCF\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Germline single nucleotide variants (SNVs) and short insertions/deletions (indels) identified using the FreeBayes pipeline from whole genome sequencing (WGS) of NF1-MPNST patient-derived xenograft (PDX) models.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"NF Service\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants (Mutect2) from WGS of NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"Germline Variants\",\n      \"WGS\",\n      \"Mutect2\",\n      \"VCF\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Germline single nucleotide variants (SNVs) and short insertions/deletions (indels) identified using the GATK Mutect2 pipeline (in germline mode) from whole genome sequencing (WGS) of NF1-MPNST patient-derived xenograft (PDX) models.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"NF Service\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Germline Genomic Variants (Strelka) from WGS of NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"Germline Variants\",\n      \"WGS\",\n      \"Strelka\",\n      \"VCF\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"GermlineVariants\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Germline single nucleotide variants (SNVs) and short insertions/deletions (indels) identified using the Strelka pipeline from whole genome sequencing (WGS) of NF1-MPNST patient-derived xenograft (PDX) models.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"NF Service\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 9,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Raw Whole Exome Sequencing Data for NF1-MPNST PDX and Human Samples\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"WES\",\n      \"Whole Exome Sequencing\",\n      \"FASTQ\",\n      \"Raw Data\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw sequencing reads (FASTQ) from whole exome sequencing (WES) of NF1-MPNST patient-derived xenograft (PDX) models and human samples. Data intended for further processing.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"Chang In Moon\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus (humanized)\"\n    ],\n    \"individualCount\": 6,\n    \"specimenCount\": 13,\n    \"measurementTechnique\": [\n      \"whole exome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Aligned Whole Genome Sequencing Data for NF1-MPNST PDX Models\",\n    \"creator\": [\n      \"Angela C. Hirbe\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"PDX\",\n      \"Neurofibromatosis Type 1\",\n      \"Preclinical Model\",\n      \"WGS\",\n      \"Whole Genome Sequencing\",\n      \"BAM\",\n      \"Aligned Reads\",\n      \"Genomics\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn11638893\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Aligned sequencing reads (BAM) from whole genome sequencing (WGS) of NF1-MPNST patient-derived xenograft (PDX) models. Includes tumor and normal samples, aligned to hg38.\",\n    \"contributor\": [\n      \"Washington University School of Medicine in St. Louis\",\n      \"Chang In Moon\"\n    ],\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus (humanized)\"\n    ],\n    \"individualCount\": 5,\n    \"specimenCount\": 11,\n    \"measurementTechnique\": [\n      \"whole genome sequencing\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7886,
    "candidatesTokenCount": 3136,
    "totalTokenCount": 11022,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7886
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn11638893"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Affinity Purified ELISA Screen\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"ELISA\",\n      \"immunoassay\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"antibody\",\n      \"monoclonal antibody\",\n      \"protein measurement\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"ELISA screening data for affinity-purified monoclonal antibodies against Neurofibromin (NF1 protein). Generated as part of the development of improved antibodies for NF1 research.\",\n    \"measurementTechnique\": [\n      \"ELISA\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Epitope Mapping\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Epitope Mapping\",\n      \"western blot\",\n      \"immunoassay\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"antibody\",\n      \"monoclonal antibody\"\n    ],\n    \"dataType\": [\n      \"immunoassay\",\n      \"image\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data from epitope mapping experiments for Neurofibromin (NF1 protein) monoclonal antibodies using western blot analysis. Images show results of antibody binding to NF1 protein fragments.\",\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\",\n      \"Dominic Esposito\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"IHC Data\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"antibody\",\n      \"monoclonal antibody\",\n      \"image\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Immunohistochemistry (IHC) images demonstrating the application of a developed Neurofibromin (NF1 protein) monoclonal antibody on various human tissue samples.\",\n    \"measurementTechnique\": [\n      \"immunohistochemistry\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\",\n      \"Michael Frost\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Sandwich ELISA\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Sandwich ELISA\",\n      \"ELISA\",\n      \"immunoassay\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"antibody\",\n      \"monoclonal antibody\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Results from Sandwich ELISA experiments using developed monoclonal antibodies against Neurofibromin (NF1 protein). Data demonstrates antibody pair performance in a sandwich assay format.\",\n    \"measurementTechnique\": [\n      \"sandwich ELISA\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Sequence Data\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Antibody Sequencing\",\n      \"Proteomics\",\n      \"Mass Spectrometry\",\n      \"Next Generation Sequencing\",\n      \"monoclonal antibody\",\n      \"Oryctolagus cuniculus\",\n      \"rabbit\"\n    ],\n    \"dataType\": [\n      \"proteomics\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Sequencing data for the developed monoclonal antibody. Includes proteomics data from mass spectrometry (LC/MSMS) and potential genetic sequence data from next-generation sequencing.\",\n    \"measurementTechnique\": [\n      \"liquid chromatography/tandem mass spectrometry\",\n      \"next generation targeted sequencing\"\n    ],\n    \"species\": [\n      \"Oryctolagus cuniculus\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\"\n    ],\n    \"individualCount\": 1,\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Titer Report\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Antibody Titer\",\n      \"ELISA\",\n      \"immunoassay\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"antibody\",\n      \"monoclonal antibody\"\n    ],\n    \"dataType\": [\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Report detailing the antibody titer results, likely determined via ELISA, for monoclonal antibodies developed against Neurofibromin (NF1 protein).\",\n    \"measurementTechnique\": [\n      \"ELISA\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Western Blot Screening\",\n    \"creator\": [\n      \"Michelle Mattson-Hoss\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Western Blot\",\n      \"immunoassay\",\n      \"image\",\n      \"Neurofibromin\",\n      \"NF1\",\n      \"antibody\",\n      \"monoclonal antibody\",\n      \"protein screening\",\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn23662493\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Western blot images used for screening monoclonal antibodies against Neurofibromin (NF1 protein). Includes tests against samples potentially derived from Plexiform Neurofibroma contexts.\",\n    \"measurementTechnique\": [\n      \"western blot\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"contributor\": [\n      \"Infixion Bioscience, Inc.\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6137,
    "candidatesTokenCount": 2071,
    "totalTokenCount": 8208,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6137
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn23662493"
}
{
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Patient Reported Outcomes Dataset\",\n    \"creator\": [\n      \"Jin-Shei Lai\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Patient Reported Outcomes\",\n      \"PRO\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Plexiform Neurofibroma\",\n      \"Quality of Life\",\n      \"Survey\",\n      \"Questionnaire\"\n    ],\n    \"dataType\": [\n      \"surveyData\"\n    ],\n    \"studyId\": \"syn4939888\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Dataset containing Patient Reported Outcomes (PRO) measures developed to assess treatment outcomes for patients with NF1-associated plexiform neurofibromas. Includes survey data from pediatric and adult patients collected via questionnaires.\",\n    \"contributor\": [\n      \"Jin-Shei Lai\",\n      \"Sara Gosline\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\",\n      \"Pain\"\n    ],\n    \"measurementTechnique\": [\n      \"questionnaire\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Plexiform neurofibromas\",\n      \"Patient outcome assessment\",\n      \"Quality of life\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5405,
    "candidatesTokenCount": 368,
    "totalTokenCount": 5773,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5405
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25",
  "custom_id": "syn4939888"
}
